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ABSTRACT 
The purpose of this study was to investigate the results of a practical 
application of a low frequency electrical stimulation (LFES) program of 8 pps to 
individuals with multiple sclerosis. Previous research has shown that such a 
program induces a conversion of fast twitch muscle properties to those of slow 
twitch. Electrical stimulation was applied for 3 hours per day, 6 days a week, for 
6 weeks, to the quadriceps femoris muscle of nine subjects with multiple sclerosis. 
Pre and post measurements of average peak torque, mean force, and fatigue slope 
were taken as indices of the muscle's strength and endurance. Contralateral 
quadriceps muscles were used as control. A two-tailed analysis of variance with 
two within subject factors was used to analyze the data. Statistical significance 
(p<. 05) was not demonstrated for the experimental leg as contrasted to the 
control leg for any of these variables; however, a strong trend for increasing peak 
torque (p<. 1 1) and mean force (p<. l O) was exhibited for the stimulated 
quadriceps muscle above that of the unstimulated control muscle. In view of the 
clinical nature of the research design, further investigation of these trends should 
be considered. Fatigability decreased in both the experimental and control legs 
suggesting a possible cross-training effect. Subjective responses were favorable 
and functional improvements were reported by all subjects. The study does 
establish LFES as a safe and comfortable option for inducing endurance exercise 
training on a muscle weakened due to MS. However, more research is needed to 
ill 
determine the extent of its usefulness and to ascertain the optimum protocol 
parameters. 
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The clinical use of neuromuscular electrical stimulation to increase strength 
and improve function in both normal and patient populations has been employed 
since the eighteenth century. 1 In this procedure, transcutaneous electrical 
impulses stimulate the peripheral nerves to produce skeletal muscle contractions. 2 
The plasticity of muscle fibers and the mutability of their contractile 
characteristics became the focus of investigations after Buller et al. 3 demonstrated 
in 1960 that muscle properties can be altered in response to neural stimuli. 
Electrical stimulation, due to its ability to elicit muscular contractions via neural 
excitation, was quickly employed as a methodological tool in research exploring 
the changes induced in muscle fibers in response to the various stimulation 
frequencies and patterns of activity delivered to them. 
Research of the biochemical and physiological effects induced in the muscle by 
electrical stimulation in animal models has been ongoing for several decades. 4•13 
These studies mainly involved stimulation to the nerve by direct contact. Studies 
with human subjects have documented similar changes primarily utilizing 
1 d c. h . l . 14-24 transcutaneous e ectro es .1or t e stmm at1on. 
1 
The results of these studies have demonstrated the capability of skeletal 
muscle properties to change in response to different electrical stimulation 
protocols. The majority of research has shown that low frequency electrical 
stimulation (LFES ), generally in the range of 8-10 Hz, can modify muscle 
properties such that fast twitch muscles express the characteristics of slow twitch 
muscles. These changes have been delineated in terms of muscle contractile 
characteristics, muscle fatigability, histological fiber types, metabolic enzyme 
activity, and myofibrillar proteins. Decreases in the muscle's fatigability have 
been noted 14' 15' 18•20 and, if the muscle is weakened by a disease process, increases 
in the muscle's strength may occur as well. 17'25 Changes are not permanent and a 
reversion to previous muscle properties occurs shortly after cessation of electrical 
stimulation. Low frequency electrical stimulation, when used to simulate the 
frequency and pattern of activity of motor neurons with slow conduction 
velocities, is thought to alter the phenotypic expression of muscle fibers as 
opposed to inducing new fiber development, or destroying pre-existing fibers. 8-10 
As a result of these findings, the clinical application of electrical stimulation 
has taken on new importance by expanding its possible therapeutic value to a 
broader patient population. Previous clinical research and application had 
primarily utilized a higher frequency electrical stimulation directed towards 
increasing the strength of musculosketally injured patients, 26 or functional ability 
of spinal cord injury patients. 27 Most commonly for these purposes, 50 bursts per 
second are delivered via a 2500 Hz carrier frequency. 2 Low frequency electrical 
2 
stimulation, usually delivered below 3 0 Hz, offers an opportunity to increase the 
endurance capacity of a muscle and, possibly, the strength of a muscle at a much 
more comfortable delivery frequency. The ability of a LFES program to increase 
muscle strength and endurance has been employed by a wide range of medical 
disciplines, from spinal cord rehabilitation23'28 to post-surgical muscle re­
education. 29'30 More recent research has included animal subjects25 and human 
subjects17'31 with neuromuscular diseases in hopes of discovering a method of 
increasing strength and endurance of muscles altered by disease. 
Scott et al. 17 utilized a low frequency electrical stimulation protocol and a 
higher ( 40 Hz) electrical stimulation m�scle testing procedure on the quadriceps 
muscle of children with muscular dystrophy. These researchers reported increases 
in the mean maximal voluntary contraction for the stimulated muscles. The low 
frequency electrical stimulation of 8 Hz, 3 hr/day, was tolerated well by the 
children and did not impede regular activity. Peckham et al. 28 reported increases 
in force and decreases in fatigability in muscles of individuals with central nervous 
system (CNS) lesions after receiving 10 Hz stimulation. Determining other 
patient populations or disease processes that may benefit from a LFES program 
merits further investigation. 
Multiple sclerosis, an adult onset neurological disease causing demyelinization 
in the white matter of the brain and spinal cord, 32'33 is a disease which may benefit 
from a LFES protocol. The clinical picture is variable and distinctive for each 
individual, reflecting the affected areas of the central nervous system, but the 
3 
overall process is of progressive decline in functional strength and ability. 34 
Evaluation of muscle characteristics in individuals with multiple sclerosis has 
suggested a transformation of fatigue resistant muscle fibers to fatigable ones, 
based on decreases in muscle endurance as determined by electrical stimulation 
testing techniques. 21 Other researchers have proposed that a conversion to Type 
II (fast twitch) muscle fibers occurs in any condition which decreases normal 
mechanical stretch or stimulus, 35 as could be the case in individuals weakened by 
disease. 
lsokinetic dynamometry has been used to document decreases in muscular 
strength and endurance of the quadriceps and hamstring muscles in individuals 
with multiple sclerosis. 36-38 A resistive exercise program has been shown to 
benefit multiple sclerosis individuals who still have sufficient strength and ability 
to participate in such a program. 39 These improvements in muscle function 
suggest the possibility that muscles in individuals with multiple sclerosis are still 
amenable to change in response to a volitional imposed training stimulus. 
Unfortunately, few options are available for the individual too weak for resistive 
training. This weaker group of multiple sclerosis individuals may stand to benefit 
most from a LFES program which can passively provide a training stimulus. 
LFES may maximize the weakened muscle's capability and possibly restore it to a 
level where volitional exercise can be initiated. 
This study seeks to incorporate the proven physiological changes in muscle 
fibers due to LFES into a viable clinical protocol and consider its utility in a 
4 
patient population. More specifically, the purpose of this study is to evaluate the 
effects of a LFES program to the quadriceps muscle of individuals with multiple 
sclerosis by assessing any changes in the muscle's strength and endurance. 
Basic Terminology 
Several terms used in the discussion of electrical stimulation research are often 
vague in their meaning. The following terms and their definitions are presented 
to clarify the intended definitions for this discussion. The Clinical 
Electrophysiology section of the American Physical Therapy Association is 
working to standardize electrotherapeutic terminology in its field. The definitions 
below are taken from the report published in 1990 by the Electrotherapy 
Standards Committee of this section of the American Physical Therapy 
Association. 40 In some cases, discrepancies which may appear in the literature are 
noted. 
Alternating Current: An uninterrupted bi-directional flow of charged particles 
which can be either symmetrical or asymmetrical. Most frequently termed AC 
current. 
Pulsed Current: Can be either a bi-directional or unidirectional flow of particles 
that periodically ceases for a finite period of time. The pulse is an isolated 
electrical event. This type of current is often erroneously called "interrupted AC", 
but this is not considered the preferred terminology. 
5 
Waveform: The visual representation of pulsed current on a current/time plot. 
Phase: Current flow in one direction for a finite period of time. It may be either 
monophasic, deviating from the zero current baseline in one direction only, or 
biphasic, deviating from the baseline first in one direction, then in the opposite 
direction. Biphasic waveforms may be either symmetrical or asymmetrical. 
Asymmetrical Biphasic: A waveform in which the deviation in one direction of 
the baseline is not equal to the deviation in the opposite direction. 
Symmetrical Biphasic: A waveform in which the deviations on either side of the 
zero current baseline are equal. 
Phase Duration: The time elapsed from the beginning to the end of one phase of 
a pulse or cycle. Usually expressed in microseconds or milliseconds. In a biphasic 
waveform, the deviation in each direction has a specific phase duration. The 
interphase interval is the period of electrical silence between each component 
phase of a pulse. 
Rise Time: The time required for the beginning of the phase to go from the zero 
baseline to its peak amplitude, often referred to as ramp up time. 
On Time/Off Time: On time is the time (usually in seconds) in which a train of 
pulses is delivered. The off time (in seconds) is the time between the trains of 
pulses. This may also be expressed as a ratio, such as 1 :2 for an on time often 
seconds and an off time of twenty seconds. This is often mislabeled as the duty 
cycle. 
6 
Frequency: For pulsed current, frequency is the number of pulses per second 
delivered and is expressed as such in ''pps". For alternating currents, frequency is 
the number of cycles per second and is expressed in hertz (Hz). The terms of 
low, medium, and high frequency are not encouraged by the Clinical 
Electrophysiology section of APTA; however, the term "low frequency" has been 
used extensively in the literature since the. onset of research in this field such that 
exclusion of this term in this paper would be most difficult, if not impossible. For 
clarification, a low frequency electrical stimulation (LFES) program in the 
literature is one in which the frequency of stimulation delivered is usually between 
8-10 Hz or pp s, and on occasion includes research protocols using frequencies of 




The progression of research on electrical stimulation and its effects on muscle 
properties can be separated according to whether animal or human models were 
used in the research design. In studies using animal models, the research can be 
considered along two lines: those studies focusing on determining what electrical 
stimulation parameters induce changes in muscle properties, and those that focus 
on determining more specifically the nature of these changes induced in the 
muscle by the electrical stimulation. Although these themes of research overlap in 
many studies, separation along these lines allows for a clearer review of the 
literature. The research using human models seeks to apply these findings in a 
practical low frequency electrical stimulation protocol in healthy and clinical 
populations with the hope of discovering a method of improving muscle function 
for clinical populations. In this literature review, research on both animal and 
human models will be covered. Subsequent to this, justification for further 
clinical investigations will also be presented, and multiple sclerosis will be 
considered as a possible disease that may benefit from a LFES program. 
8 
Animal Models 
Research Determining the Appropriate Electrical Stimulation Parameters: In 
1960, Buller et al. 3 published the results of their cross-innervation experiments on 
the hindlimb of cats. This study reported that slow twitch muscles, when cross­
innervated with motor neurons from a fast twitch muscle, transformed in such a 
manner that the slow twitch muscles expressed the contractile properties of the 
fast twitch muscle. The predominantly slow twitch soleus muscle was noted to 
have a decrease in contraction time and in half-relaxation time after cross­
innervation from a predominantly fast twitch flexor digitorum longus muscle. The 
reverse was also found to be true. Fast twitch muscles, cross-innervated with 
motor neurons from the slow twitch muscles, expressed the muscle contractile 
characteristics associated with slow muscles, demonstrating a slowing in 
contraction time and half-relaxation time. These findings led the authors to 
generally conclude that the speed of a muscle is determined by the motor neuron 
innervating it, and that this muscle property is mutable. The neural influence 
responsible for this was considered to be mediated by a substance passing down 
the axon and going into the muscle fibers. They further determined that this neural 
influence was exhibited in adult cats as well as in developing young kittens, 
indicating that this process continued throughout life. The concept of a 
''neurotrophic influence" in this hallmark study spawned research investigating 
other plausible mechanisms by which the motor neuron may determine or alter the 
characteristics of muscle. Electrical stimulation became a widely used 
9 
methodological tool in these types of studies due to its ability to emulate different 
motor neuron transmission traits. 
As an alternative concept to the transmission of a neural substance, the 
results of two studies by Vrbova4'41 suggested that impulse activity in the motor 
neuron may be responsible for changes in muscle properties. Vrbova first 
documented the typical electromyographic (EMG) activity of slow twitch and fast 
twitch muscles by performing tenotomies in rabbits. 41 Slow twitch soleus muscles 
were noted to exhibit a continuous EMG activity, in contrast to fast twitch 
muscles which demonstrated occasional bursts of activity on an otherwise silent 
background. Subsequent to this study, Vrbova analyzed the effects of motor 
neuron activity on muscle speed characteristics. 4 In a series of experiments, 
Vrbova created conditions of decreased impulse activity on the soleus muscle by 
performing tenotomies of all the tendons around the ankle joint of rabbits and 
cats. This resulted in the slow soleus muscle exhibiting shorter contraction and 
relaxation times, similar to that of fast twitch muscles. The researchers attributed 
these changes to the decreased impulse activity in the motor neuron. The already 
fast twitch plantaris muscle did not exhibit these changes. Conversely, excessive 
use of a muscle resulted in slower contraction and relaxation times, whether it was 
a slow twitch muscle like the soleus, or a fast twitch muscle such as the plantaris, 
extensor digitorum longus, or tibialis anterior. Vrbova attributed the slowing of 
contractile characteristics of both muscle types to the increased impulse 
transmission from the overload condition. Although Vrbova concluded impulse 
10 
activity of the motor neuron was important in determining the mechanical 
responses of muscles, no distinction was made as to whether these changes were 
due to the frequency, or the duration of the motor neuron discharge. 
Salmons and Vrbova5 expanded upon the findings of impulse activity affecting 
contractile characteristics by testing different frequencies of electrical stimulation 
to the tenotomized soleus muscle of rabbits. Previous studies had indicated that 
motor neurons to slow twitch muscles discharge at a frequency of l O to 20 
impulses/second and those to fast twitch muscles discharge at 30 to 60 
impulses/second. 42 Salmons and Vrbova postulated that subjecting muscles to 
different frequencies of activity should alter the muscle's contractile 
characteristics. They found that the tenotomized slow twitch soleus muscle could 
be prevented from acquiring the faster contraction and relaxation times associated 
with ·tenotomy if long term electrical stimulation using a frequency of 5 or I 0/sec 
was done after tenotomy. However, stimulation at a higher frequency of 20 or 
40/sec did not prevent the acquisition of fast twitch muscle characteristics after 
tenotomy. Conversely, continuous stimulation at l 0/sec for up to 6 weeks to the 
fast twitch tibialis anterior and extensor digitorum longus muscles of the rabbit 
resulted in these muscles exhibiting slower contractile characteristics. The study 
emphasized the importance of the frequency of the impulse activity in determining 
muscle characteristics. A further point of interest is how the researchers related 
the frequency and impulse activity imposed upon a muscle to the function of that 
muscle, as in locomotion. Muscles such as the soleus which are involved in 
11 
maintaining balance and posture, should be expected to exhibit slower contraction 
and relaxation times as compared to muscles more typically involved in rapid 
reflexive movements such as the flexor hallicus longus. In this way, muscles are 
able to specifically adapt to their particular functional role. 
The frequency and duration of electrical impulses were not the only factors 
being investigated for possible influences on the contractile characteristics of 
muscles. Lomo et al. 6 studied the effect of the pattern of activity imposed upon 
the muscle by electrical stimulation. N eurotrophic factors were eliminated by 
resecting part of the sciatic nerve in rats, allowing for experimentation on 
denervated slow twitch soleus muscles. Two groups of rats received stimulation 
to their soleus muscle. The mean frequency of the stimulation was 2 Hz in both 
groups, although different delivery methods to each group resulted in two 
different patterns of muscle activity. One group received I 00 Hz stimulation for 
. 5 seconds repeated every 25 seconds to simulate the briefer, phasic activity of 
fast twitch muscles. The other group received IO Hz stimulation lasting I 0 
seconds and repeated_ every 50 seconds in an effort to mimic the more tonic 
activity of slow twitch muscles. Stimulation was performed in vivo for 3 to 6 
weeks. The different training protocols resulted in the two groups exhibiting 
different muscle contractile characteristics. The soleus muscles stimulated with 
the phasic pattern of activity demonstrated contractile characteristics more typical 
of fast twitch muscles than normal slow twitch soleus muscles. The muscles 
stimulated with 10 Hz, the more tonic activity pattern, had contractile properties 
12 
similar to normal soleus muscles. The observed changes in muscle contractile 
characteristics were supported by muscle biopsies. This finding is complementary 
to Salmons and Vrbova 's5 determination that slow to fast changes in contractile 
characteristics of a tenotomized soleus muscle could be prevented with long term 
low frequency electrical stimulation. This change was not prevented with the 
phasic pattern of stimulation. 
Lomo and associates6 also noted that the conversion to fast twitch muscle 
properties was not complete in this study. The 100 Hz stimulated muscles did not 
exhibit a characteristic "sag" in tension seen in Type II muscles during the initial 
response to tetanic stimulation. These stimulated muscles also continued to be 
more fatigue resistant in tetanic stimulation than normal fast twitch muscles. This 
led the investigators to suggest that endurance and contractile speeds of muscle 
may be controlled separately, with resistance to fatigue more specifically related 
to the overall pattern of activity in the muscle. A similar finding had been noted by 
Buller et al. 3 
Hudlicka et al. 43 gave further support for the importance of the overall amount 
of activity, as opposed to the stimulation frequency, in inducing changes in muscle 
contractile characteristics. These researchers included resistance to fatigue during 
isometric twitch as a contractile property of the muscle. The fast twitch muscles 
of two groups of rabbits were stimulated and compared to a control group. The 
pattern of activity was the same for both experimental groups with continuous 
electrical stimulation being delivered 8 hours a day for 28 days; however, one 
13 
group received 10 Hz stimulation while the other group received 40 Hz 
stimulation. Muscle contraction time and resistance to fatigue during isometric 
twitch contraction were increased in both experimental groups, and indicated a 
slowing of the muscles stimulated regardless of the frequency. The 10 Hz 
stimulation was reported to yield greater and more consistent increases on these 
two muscle properties. Resistance to fatigue was quantified by delivering 4 Hz 
electrical stimulation continuously for IO minutes; the muscle tension produced at 
the end of the stimulation was expressed as a percent of the maximum tension 
developed during this period. The researchers also noted that peak tension 
decreased during the first few days of electrical stimulation in both groups as 
compared to the control group, but this difference was not apparent after 14 days 
of stimulation. By the end of 28 days, the muscles stimulated at 40 Hz developed 
more tension than either the control group or the 10 Hz group. Decreases in fiber 
diameter were seen in conjunction with a change from Type II to Type I fibers in 
the 40 Hz stimulated group. Results were not reported for the 10 Hz stimulated 
group. 
Sreter et al. 12 expanded upon the findings of Hudlicka et al. by stimulating the 
same fast twitch muscles in rabbits at 60 Hz for 2. 5 seconds every 10 seconds, to 
emulate the higher frequency phasic pattern of stimulation. This was considered 
similar to that naturally received by fast twitch muscles; however, the stimulation 
was delivered continuously for 5 weeks. This resulted in the same transformation 
of fast to slow twitch muscle properties, as determined by histochemistry, myosin 
14 
ATPase activity, and myosin light chains, that lower frequencies of stimulation 
had induced. The changes exhibited a gradual evolutional process and emphasized 
the total amount of muscle activity induced by stimulation as being influential in 
transforming muscle fiber properties. Eerbeek et al. 44 confirmed similar 
transformations from fast to slow twitch muscle characteristics regardless of 
whether the stimulation was at a low or high frequency, as long as the stimulation 
activity was greater than 50 percent of the total activity time. 
As a result of the above studies, the ability to transform a muscle from the 
expression of fast twitch muscle characteristics to that of slow twitch muscle 
characteristics became a well established concept. The idea of the pattern, or 
total amount, of activity as being influential in inducing these changes, instead of 
just the frequency of stimulation delivered, became apparent. While these 
determinations were being made, other investigators were considering the nature 
of the changes in the muscle fibers induced by the electrical stimulation. 
Research Determining the Nature of Changes in Muscle Properties: One of the 
earlier investigations in this area was done by Brown et al 45 These researchers 
sought to determine the mechanisms responsible for the increased resistance to 
fatigue as a result of LFES. Rabbit tibialis anterior and extensor digitorum longus 
muscles, typically fast twitch muscles, were stimulated at a frequency of I O  Hz, 8 
hours a day, for 2 to 28 days. The researchers concluded that the chronic 
stimulation caused an increase in capillary number allowing for more blood flow 
1 5  
into the muscle. Since no increase in glycolytic enzymes were noted, but an 
increased activity of fatty acid activating enzyme did occur, the investigators 
concluded that this may be suggestive of the muscles using more fats as a source 
of energy. 
With improvements in technology, researchers were able to discern in greater 
detail the changes that occurred in contractile characteristics, histological profiles, 
and immunocytochem.ical profiles, as a result of electrical stimulation programs; 
this lent more support for the plasticity of muscle properties. The preponderance 
of the studies focused on the conversion of fast twitch muscles to slow twitch 
muscles using a low stimulation frequency. 7 •8 • 1 0• 1 1 •43 •46 
Pette et al. 8 investigated the time sequence of changes in time to peak twitch, 
enzyme activity, myosin light chains, and fiber type in the fast twitch tibialis 
anterior and extensor digitorum longus of rabbits in response to long term LFES 
programs. Stimulation was delivered at I O  Hz in either an intermittent protocol of 
8 hours per day, or a continuous protocol of 24 hours per day, for durations of 3 
to 62 days. Changes in the contractile characteristic and enzyme activity occurred 
before changes in fiber myosin light chains and fiber type distribution were 
discernible. All changes demonstrated a relationship with the amount of time the 
stimulation was administered. In the 8 hour per day protocol, changes in light 
chain pattern did not occur until after 60 days of stimulation, even though the 
contractile property of time to peak isometric twitch contraction appeared after 3 
1 6  
weeks. Changes in light chains were more rapid in the continuous protocol of 24 
hours a day; this occurred after 3 weeks of stimulation. 
Rubenstein et al. 10 gave more insight into the changes induced in muscle 
myosin and the incomplete nature of its conversion due to electrical stimulation. 
Ten Hz stimulation frequency was applied to the tibialis anterior, extensor 
digitorum longus, and peroneal muscles via the peroneal nerve in rabbits. 
Changes in fast and slow myosin were noted in response to the LFES. With 
stimulation, most muscle fibers showed the presence of both fast and slow myosin, 
with progressive increases in slow and decreases in fast myosin as the stimulation 
time was extended. This contrasts with the unstimulated muscles which stained 
predominantly as fast twitch. The authors ascertained that the presence of both 
myosin types in the muscle fiber supported the contention that pre-existing fibers 
are reprogrammed, resulting in a switching of fast to slow myosin synthesis, as 
opposed to the muscle being permanently programmed to be either slow twitch or 
fast twitch. The incomplete conversion reported by previous researchers, and 
thought by some to be due to the stimulation source being artificial, 6 was now 
being considered a reflection of the transitory state of the muscle fiber. 
Hudlicka et al. 46 investigated changes in blood flow, capillary density, fuel 
metabolism, and endurance characteristics in fast twitch muscles of rabbits using 
the previously discussed protocol comparing groups stimulated with 10 Hz and 40 
Hz with a control group. The 8 hours a day stimulation for 28 days showed 
increases in blood flow, capillary density, oxygen consumption during contraction, 
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and endurance, as well as a shift from anaerobic to aerobic metabolism in both 
experimental groups, irrespective of the frequency of stimulation delivered. 
Endurance was quantified by electrical stimulation as described in the previous 
report by Hudlicka et al. 43 A difference was detected in lactate output, with the I 0 
Hz group having lower lactate output than the 40 Hz group or the control group, 
which were similar. 
In the two reports by Hudlicka et al. , the authors commented on a limitation in 
the use of different electrical stimulation frequencies in attempting to simulate 
slow and fast motor neuron patterns. 43 '46 The I O  Hz frequency was considered 
close enough to the naturally occurring frequency found in slow twitch muscles; 
however, they did not feel that 40 Hz mimicked fast motor units sufficiently, since 
only an unfused tetanus contraction was produced in the muscle. The limitation 
laid in the inability of conscious animals to tolerate the discomfort produced by 
higher frequencies of long periods of stimulation. Even if this is regarded as a 
possible limitation, the results of the study give evidence of the plasticity of a 
wide array of muscle properties in response to a LFES program given over a 28 
day period. 
Heilig and Pette7 studied changes in enzymes in response to a long term 
application of a LFES program ( I O  Hz, 12  hours a day) on the predominantly fast 
twitch rabbit tibialis anterior muscles. They found decreases in glycolytic enzyme 
activity and increases in mitochondrial enzyme activity, providing evidence of the 
shift from anaerobic fuel metabolism to aerobic substrate oxidation . These 
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changes in enzymatic activity pattern were considered integral to the increased 
resistance to fatigue reported in muscles chronically stimulated with a low 
frequency. 
Heilig and Pette found that increases in some enzymes and decreases in others 
began within one day of stimulation. Enzymes whose activity was increasing 
reached complete transformation before those that were decreasing. Changes due 
to the LFES were also documented in isoenzymes of lactate dehydrogenase 
(LOH), as soon as 3 days after stimulation onset, and were offered as further 
support for the capability to modify gene expression by altering the pattern of 
activity of the muscle. 
LFES has also been proven to alter intracellular biochemistry and membrane 
potential of fast twitch tibialis anterior muscles of rabbits. 1 1  Complete 
transformation of the fast twitch muscle to slow twitch muscle was confirmed 
after 5 weeks of continuous 8 Hz stimulation. After the LFES program, increases 
also occurred in intracellular sodium with commensurate decreases in intracellular 
potassium. No change was observed in intracellular magnesium, but a transitory 
increase in intracellular calcium was noted which returned to normal by 2 to 3 
weeks of stimulation. Membrane potential also decreased in line with a fast to 
slow transformation. Of particular interest in this study was the temporary nature 
of changes in intracellular sodium and potassium, and in the membrane potential, 
after cessation of the stimulation. Many previous studies had documented a 
return to fast twitch muscle contractile characteristics, myofibrillar proteins, and 
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enzymatic activity, within several weeks after the stimulation had been terminated. 
In marked contrast to the time course of these changes, intracellular sodium, 
potassium, and membrane potential began reversal to their original fast twitch 
levels within 1 0  minutes after stimulation ceased, and were complete within 30  
minutes. The resear�hers offered this finding as proof that long term low 
frequency electrical stimulation does not cause any membrane damage. 
Some discussion in the literature occurred over where and what type of 
morphological transformation was transpiring in the stimulated muscles. After 
reviewing the results of many research investigations, Salmons and Henriksson47 
noted that the preponderance of evidence indicates a transformation of fast twitch 
to slow twitch occurs within each fiber, as opposed to hypertrophy of slow twitch 
fibers with commensurate degeneration of fast twitch fibers. Several tenants for 
this conclusion are enumerated by the authors, with the incomplete nature of the 
conversions in histochemical, biochemical, and physiological properties being a 
major contributing factor. 
Debate over when a transformation represents a change from Type II fibers to 
Type I fibers as opposed to Type lib to Type Ila also emerged. Mabuchi et al. 4 8  
investigated the fast to slow twitch muscle property changes associated with 
intermittent LFES in comparison to previous changes documented in continuous 
LFES. They claimed that previous studies of intermittent LFES had documented 
changes primarily in metabolic enzymes, but not in myosin light chains sufficiently 
enough to indicate changes from Type II to Type I fibers. Mabuchi et al. 
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contended that a LFES program of 1 0  Hz, 8 hours a day for 7 weeks, resulted in a 
transformation of Type II subtypes, from Type lib to Type Ila. These changes in 
myosin subunit structures of Type II fibers were seen as an intermediary stage in 
the fast to slow transformation, and were a result of the intermittent stimulation 
pattern. 
In a subsequent review paper, Pette9 questioned the meaning of classifying 
fibers into subtypes of Ila and lib when they are in a transformation process. In 
general, he queries the idea of fiber type classification altogether. In this 1984 
publication, Pette9 updates his 1976 report, 8 and details the sequencing of events 
in the transition of fast twitch to slow twitch muscles in animals due to the 
increased contractile activity imposed by electrical stimulation. Initial changes in 
contractile characteristics are due to changes in the release and uptake of Ca 2+ due 
to alterations in the sarcoplasmic reticulum. Commensurate with this, metabolic 
enzymatic activity changes cause an increase in aerobic oxidation capacity and a 
decrease in anaerobic glycolytic capacity. Changes in LDH also occur in this 
stage. The resultant increase in mitochondria causes a white to red 
transformation. Total ribonucleic acid (RNA) activity is seen to increase with 
stimulation until plateauing after four weeks of continuous stimulation. Finally, as 
electrical stimulation continues, changes in the myosin subunits, or light chains, 
occur. At this time, histochemical staining indicates a conversion of Type II to 
Type I. Pette does not specifically address changes in muscle fatigability, so it is 
not known for certain where this muscle property may fall on the spectrum. Other 
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researchers have reported changes in muscle fatigue in response to tetanic 
stimulation simultaneously with changes in contractile properties. 1 4• 1 5 •43 
Pette emphasizes that such an orderly sequencing of events due to the 
stimulation is much more indicative of a transformation of one fiber type as 
opposed to the exchange of one fiber type for another. As a result of all of the 
above changes in the multiple systems of the muscle, the muscle is viewed as an 
extremely adaptive tissue in response to demand. Increased activity, as imposed 
by a LFES program, is considered to induce an alteration in the muscle from fast 
twitch characteristics to slow twitch characteristics. 
Dangain and Vrbova25 examined the effects of a LFES program on diseased 
muscles. A protocol of I O  Hz stimulation was delivered to normal and dystrophic 
mice. The greatest increase in force output after stimulation was seen in the mice 
that were the weakest initially. Similar to the findings of Hudlicka et al. 43 in 
rabbits, the strongest mice showed an initial minor and transitory decrease in force 
output. This was considered by the authors to be due to a replacement of 
contractile proteins by mitochondria. 
Thus far, much of the animal research had been predominantly focused on 
changing fast twitch muscle to slow twitch muscle by using electrical stimulation 
in a frequency and pattern of activity which imitated that normally delivered to 
slow twitch muscles. The transformation had been documented by a multitude of 
muscle properties such as contractile characteristics, resistance to fatigue, fiber 
type, enzymatic activity, myosin light chains, and intracellular chemistry. 
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The reverse procedure, inducing change in �uscle properties from slow twitch 
to fast twitch posed a greater challenge to research technique, and most probably, 
was influential in directing the focus of future research as it progressed into 
human models. The technical problem arose in trying to completely eliminate the 
normal input to the muscle, which would be required to remove the slow motor 
neuron influence. 49 Stimulation at a higher frequency, e.g. , 60 Hz, had been 
shown to result in a fast to slow transformation even though a phasic pattern of 
stimulation had been applied, since the overall pattern of activity imparted to the 
muscle was high. 12 To test an intermittent phasic stimulation pattern mimicking a 
fast motor neuron, all other neural inputs must be controlled, or more specifically, 
silenced. This could be done by cross innervation, 3 denervation, 6•5 0  or 
tenotomy. 4'4 1  An obvious limitation exists in applying these methodologies to 
human subjects. Another limitation with human subjects is the cutaneous 
discomfort experienced by the subject when using a higher frequency of 
stimulation. Most likely, these technical limitations guided future research with 
human models leading to the use of 30-50 Hz for short term applications of 30 
minutes or less, 26•5 1 •52 and 8-15 Hz for longer stimulation durations. 1 4 ' 1 5 •20 
LFES Research in Human Models 
In 1976, Peckham et al. 28  was one of the earlier researchers to investigate 
muscle contractile changes in human subjects in response to electrical stimulation. 
An electrical stimulation frequency of 10-15 Hz was applied for 2 5 weeks to the 
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finger flexors of 12  subjects with quadriplegia . Ten of the subjects had electrodes 
implanted under the skin and into the muscle belly, while the other two used 
transcutaneous electrodes. Significant increases in contractile force and 
endurance were reported in response to the electrical stimulation testing 
methodologies used in the study. It may be erroneous to ascribe all of the noted 
increase in these measurements to the electrical stimulation because all 1 2  of the 
subjects were less than one year post injury, leaving spontaneous recovery as a 
possible confounding factor in strength and endurance increases. No control 
group was provided. 
Edwards and colleagues 14 investigated changes in the adductor pollicus muscle 
of two healthy subjects in response to I O  Hz stimulation applied transcutaneously, 
3 hours a day for 6 weeks, using a small portable stimulator. Fatigue testing was 
accomplished by recording the decrease in muscle tension which occurred in 
response to a sequence of brief trains of 40 Hz stimulation. A ratio of muscle 
tension produced at 3 minutes compared to the initial tension was taken as the 
fatigue index. Increases in the fatigue index, representing an improvement in 
muscle endurance, was one indicator used to document a conversion to slow 
twitch muscle properties after 2 to 3 weeks of stimulation. The researchers 
proposed that these changes were due to alterations in fiber typ e composition; 
however, histological fiber typing was not performed. 
Dubowitz et al. 15 used the above methodology to establish force-frequency 
curves and fatigue indexes for the extensor digitorum longus and tibialis anterior 
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muscles in four healthy adult female subjects. Low frequency stimulation of 8- 1 o 
Hz was applied for 1 hour, 3 times per day, for 6 weeks. Results indicated a 
highly significant (p=. 0 1) improvement in the fatigue index. Neither Edwards et 
al. 1 4  or Dubowitz et al. 15 found changes in maximal voluntary contraction from the 
stimulation program, but both groups of researchers concluded that the contractile 
properties of human muscles were amenable to change via a long term LFES 
program. 
Scott et al. 1 6  applied LFES (8- 10  Hz, 3 hours per day, for 6 weeks) to the 
tibialis anterior muscles of 1 6  adults and 1 8  children. The fatigability of the 
muscle was measured using the 40 Hz stimulation testing protocol. Although the 
results demonstrated a significant reduction (p<. 0 1) in the fatigability of muscle in 
adults, improvement in the muscle endurance was not noted in the children. They 
concluded that the properties of adult human muscle could be altered by a LFES 
program, and that it could potentially benefit patient populations with 
neuromuscular disease. 
Rutherford and Jones20 stimulated the adductor pollicus and first dorsal 
interosseus in 1 0  healthy human subjects using a small portable stimulator with 
transcutaneous electrodes. Electrical stimulation testing methods were used for 
quantifying changes in muscle contractile characteristics and fatigability. 
Maximum voluntary contraction was used to assess strength changes in the 
muscle. The stimulation protocol was similar to previous studies in that it was 
applied for 3 hours a day for 6 weeks; however, two stimulation patterns were 
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used in this evaluation. One group of five subjects received a uniform 10 Hz 
stimulation frequency as in the previous reports, while the other group of five 
subjects received a non-uniform pattern of 10 Hz stimulation interspersed with 
bursts of 50  Hz frequency (10 every 6 .5  seconds). Both groups demonstrated an 
improvement in fatigue resistance in the stimulated muscles; the researchers 
attributed this to an increase in capillary density and oxidative enzymes. One of 
the more notable findings in the study was the difference in maximal voluntary 
contraction between the two groups. The uniform 10 Hz stimulation frequency 
resulted in a slight decrease in the maximal strength output; this decrease in 
maximal strength was not noted in the non-uniformly stimulated group. The 
investigators stress�d the clinical importance of the non-uniform pattern for 
individuals whose muscle strength may be weakened by disease. 
Scott et al. 17 developed a protocol for children with muscular dystrophy in 
which a LFES program of 8 Hz, 3 hours per day, 6 days a wee_k, for 7 to 11 
weeks was applied to the quadriceps muscle. Maximal voluntary contraction was 
assessed, as well as electrical stimulation testing of resistance to fatigue. Small, 
but significant increases in strength resulted from the children receiving 10 weeks 
of LFES. This may be an extension of the concept introduced by Dangain and 
Vrbova25 in dystrophic mice which suggested that a greater likelihood of strength 
increase may occur in muscles that are initially weak. Support for this may also be 
represented in the research results of Peckham et al. 28 on individuals with 
quadriplegia. LFES may promise increases in strength to the weakest clinical 
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populations that stand to benefit from it most, whether the weakness is from a 
peripheral muscular disease, such as muscular dystrophy, or a central nervous 
system (CNS) lesion such as quadriplegia. 
The findings of Scott et al. 1 7  relating to muscle endurance merit discussion. 
Although resistance to fatigue was measured by electrical stimulation testing at 40 
Hz as seen in other studies, most of the children in the study did not tolerate this 
testing protocol because it was too uncomfortable. In the five children that did 
complete the testing, no changes in the endurance of the muscle were indicated by 
the fatigue index. There are some plausible explanations for this result. One 
possibility is that the LFES did not induce any changes in fatigue resistance of the 
muscle. In an earlier study by Scott et al. , 1 6  healthy children, in contrast to the 
adult subjects, did not experience an increase in fatigue resistance as a result of 
LFES. This may suggest that responses to a LFES program vary with age. 
Another possible contention is that testing muscle contractile characteristics at 40 
Hz is not the best assessment method for clinical populations, such as the children 
with muscular dystrophy. Any pathological condition which increases the fat or 
connective tissue in a muscle can make higher frequencies of electrical stimulation 
uncomfortable because it causes an increased resistance to the electrical impulse. 27 
This would become particularly apparent when a large muscle group such as the 
quadriceps is stimulated. Lastly, it is also possible that the subject number of five 
that was able to complete the electrical stimulation testing, did not result in 
enough statistical power to detect any significant changes. The endurance 
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response of muscle to LFES requires further research in patient populations to 
answer these questions. 
LFES protocols involving human subjects have primarily restricted their 
evaluation to the contractile properties and fatigability of muscle. Gauthier et al. 22 
provide data linking the sequence of changes previously determined in animals 
with corresponding changes in humans in response to low frequency electrical 
stimulation. A LFES program (8 Hz, 3 hours per day, 6 days a week, for 6 weeks) 
to the quadriceps muscle was evaluated for its effects on metabolic enzymes in 16 
men and 10 women. As in animals, enzyme activity of the Krebs cycle, electron 
transport chain, and fatty acid oxidation were significantly increased after the 
electrical stimulation program. No changes occurred in enzymes associated with 
glycolytic pathway activity. 
As reported earlier by Pette9 in 1984 on animal subjects, changes in the 
enzymatic activity and contractile characteristics occur in conjunction with total 
RNA activity, and are a precursor to histological demonstration of fiber type 
changes. One of the first studies to demonstrate changes in fiber types as a result 
of a LFES program was by Martin et al. 24 in 1992 . Muscle biopsies performed on 
the tibialis anterior muscle of spinal cord injured subjects showed average 
increases of 25% of Type I muscle fibers after 24 weeks of stimulation at 20 pps. 
Th� protocol called for gradually increasing the stimulation duration in 6 week 
increments from 45 minutes initially, to 8 hours a day the last 6 weeks. Stein et 
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al. 23 also reported increases in the muscle's endurance and oxidative capacity with 
this protocol. 
The practical application and clinical benefits of a LFES program have not 
been limited to spinal cord injuries or neuromuscular diseases. Low frequency 
electrical stimulation has also been used in post-surgical rehabilitation. 
Transposition of the gracilis muscle to correct anal incontinence (gracioplasty) is 
a procedure that had been applied for several years but with limited success 
because of the quick fatigability of the gracilis muscle. Baeten et al. 29 and Konsten 
et al. 30 used a LFES program to transform the muscle properties of the gracilis 
from that of fast twitch to that of slow twitch. In the reports by these researchers 
the percentage of Type I muscle fibers increased from 44% to 63 % after 16 weeks 
of stimulation at 25 Hz frequency. Tremendous functional improvements were 
also reported by the two research teams. Not only do Baeten et al. and Konsten et 
al. document fiber type changes due to LFES, but also the results of their studies 
demonstrate· the viability of LFES as a therapeutic tool in clinical rehabilitation. 
Justification for Further Clinical Application of LFES 
The present body of knowledge supports future inquiry into the potential 
therapeutic effects of LFES in patient populations for increasing muscle 
endurance, and possibly, muscle strength . LFES would seem to be advantageous 
in pathological conditions typified by a conversion to, or preponderance of, Type 
II muscle fibers since it induces the expression of slow twitch muscle 
29 
characteristics. Benefits from a LFES program could include a reduction in the 
fatigability in the stimulated muscle. Much attention in the literature has been 
directed towards discerning if particular diseases occur in association with 
specific fiber type atrophy or proliferation. In 1970, Edstrom53 reported a 
decrease in Type II muscle fibers in individuals with upper motor neuron lesions 
such as cerebral vascular accidents, Parkinsonism, and spinal cord injury. More 
recent literature reviews expressed a consensus of Type I to Type II fiber 
conversion, with commensurate decreases in functional strength and endurance, in 
conditions of paralysis (whether from spinal cord injury or other causes), 
immobilization, or weightlessness. 49'54 A review by Gordon and Pattullo 49 
explains that the earlier conclusion of Type II atrophy was the result of 
researchers counting fibers as Type I when their phenotype had actually changed 
to Type II, although their size remained small like a Type I fiber. Goldspink et 
al. 35 have postulated the existence of a "default" myosin gene resulting in the 
expression of Type II muscle characteristics under conditions of altered use, 
irrespective of etiology. According to this theory, muscle fibers in the absence of 
stretch and certain mechanical stimuli, revert to the expression of the fast myosin 
gene leading to a greater Type II fiber population in the muscle. Ostensibly, this 
could be the case in conditions of tenotomy, spinal transections, or neuromuscular 
diseases in which the input of normal mechanical stimuli is limited. Current 
thought seems to consider muscle fiber type expression in pathological conditions 
to be complex and variable, resulting from the interplay of many factors. 49 
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Whether a muscle is a flexor or an extensor, or whether it crosses one or two 
joints, affects the muscle fiber type expression. The weightbearing status, the 
amount and pattern of neuromuscular activity (as in muscle spasticity), and 
hormonal input also influence the expression of muscle fiber type. The general 
trend is for fiber atrophy and conversion to be greater in slow twitch extensor 
muscles, particularly those involved in weightbearing, than in fast twitch extensors 
or flexor muscle groups. 49'54 
LFES may also offer potential benefit to disease processes which are non 
selective in fiber type atrophy, but which result in deficits in muscular strength. 
As demonstrated in the study by Peckham et al. 28 in individuals with quadriplegia, 
Dangain and Vrbova25 in dystrophic mice, and Scott et al. 17 in children with 
muscular dystrophy, a LFES program can cause increases in strength in muscles 
that are atrophied and weak due to a disease process. 
A LFES program may offer therapeutic advantages to patient populations 
based on two premises. First, in pathological conditions which result in increased 
muscle fatigability, possibly due to a Type II fiber predominance, LFES may alter 
the gene expression of muscle contractile properties from that of fast twitch 
muscles to that of slow twitch muscles, in a manner similar to that induced by an 
endurance exercise program. Second, in diseases typified by substantial decreases 
in strength and functional ability, LFES may provide a viable method of imposing 
contractile activity on the skeletal muscle above the individual's volitional 
capability, and at a frequency that is comfortable for the individual. The low 
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frequency of 8- 10 Hz or pp s allows better tolerance of the electrical stimulation 
current, thereby permitting more use by an individual. Reports of electrical 
stimulation of higher frequencies ( 40 and 50 Hz) in neuromuscular conditions 
have been negative in terms of subject tolerance, whether the stimulus was used in 
testing muscle contractile properties, 17 or in trying to increase muscle strength as 
a clinical treatment option (D. R. Sinacore, PhD, verbal communication, October 
1993). 
One of the current challenges involves discerning the patient populations and 
disease process which may benefit from a LFES program. Children weakened by 
muscular dystrophy and individuals recovering from spinal cord injury or surgical 
interventions have demonstrated improvements in response to LFES. Most 
probably, individuals with other disease processes could benefit from LFES as 
well. Multiple sclerosis may be such a disease. 
Potential Benefits of LFES for Individuals with Multiple Sclerosis 
Multiple sclerosis (MS) is an adult onset progressive disease characterized by 
demyelinization in the white matter of the brain and spinal cord. 32•33 The etiology 
of the disease remains unknown, but speculation of environmental and genetic 
components continue. ss Mitchell33 describes three clinical forms of the disease: 
( 1) relapsing/remitting with remissions and exacerbation; (2) relapsing/progressive 
with less complete recovery after exacerbations; and, (3) chronic progressive 
which is typified by spinal cord and cerebellar dysfunction. This last form is 
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usually a progression of the relapsing/remitting process. All forms may result in a 
progressive decline in strength and functional ability, although the rate of decline 
and amount of dysfunction are highly variable. Functional deficits mirror the sites 
of the demyelinating lesions and ·frequently result in decreased ambulatory 
capacity. Progression may be severe enough to result in a non-ambulatory 
status. 34 
The thrust of medical treatment has been palliative in nature, utilizing a 
multitude of medications. 34 '3 7  Currently a new drug, beta seron, aimed at stalling 
the disease progression is being marketed. Clinical offerings in terms of physical 
rehabilitation have been limited to stretching and strengthening exercises 
combined with training in the appropriate use of assistive devices. 
Recently controlled studies quantifying the musculoskeletal and physiological 
responses of individuals with multiple sclerosis have been done. 57 Armstrong et 
al 36 and Ponichtera et al. 38 demonstrated that isokinetic dynamometry is safe and 
reliable for testing quadriceps and hamstring muscles in MS individuals. These 
studies also documented decreases in the peak torque of these muscles in subjects 
with multiple sclerosis in comparison to matched healthy individuals. Chen et al. 37 
used isokinetic dynamometry to establish decreases in the time-rate of muscle 
tension development and muscle tension-maintaining capacity of the quadriceps 
and hamstrings in subjects with MS in comparison to a matched healthy control 
group. V02 max has also been shown to be significantly lower in individuals with 
MS as compared to a healthy control group matched for gender, age, weight, 
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height, and lifestyle. 58 One of the few published reports dealing with the response 
of individuals with MS to a exercise treatment regimen is provided by Gehlsen et 
al. 39 In this study isokinetic dynamometry documented changes in muscle 
strength and endurance in both upper and lower extremities in subjects with MS as 
a result of an aquatic exercise program. 
There is a paucity of data documenting changes in histological fiber type due 
to the disease process of MS. Lenman et al. 21 evaluated muscle contractile 
characteristics in the tibialis anterior muscle of individuals with MS utilizing 40 
Hz electrical stimulation. These investigators determined that individuals with 
MS show a greater fatigability and an increased half-relaxation time in the tibialis 
anterior muscle when contrasted with healthy subjects. Based on these contractile 
properties, the researchers suggested that the prolonged disuse associated with 
MS changed fatigue-resistant fibers into fatigable ones. This finding would 
concur with the literature consensus previously discussed which contends that 
CNS lesions most likely result in a conversion from Type I to Type II fibers. It 
may also be in accordance with the suggestion of Goldspink et al. 35 of Type II 
fibers being present as a result of default myosin gene expression in response to 
the normal mechanical input being altered. 
Without muscle biopsy and histological fiber typing data, a definitive alteration 
in muscle fiber type in association with MS can not be known. The fiber type 
morphology most likely varies according to the multiple factors previously 
introduced as being influential in determining fiber type expression in disease 
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processes such as spasticity, weightbearing status, flexor or extensor muscle 
status, and hormonal input. 
What is known is that in individuals with MS there are documented decreases 
in muscular strength and endurance2 1 •36-38 and, ultimate functional disability. 34•5 6  
Resistive exercise programs have proven beneficial in increasing the strength of 
individuals with MS that have sufficient physical ability to participate in them. 3 9  
However, fewer options are available to individuals with MS whose decreased 
functional strength is so great as to preclude participation in such resistive 
exercise training. For this group of individuals with MS, a LFES program may 
offer an alternative method of imposing increased activity upon the muscle. The 
increased muscle fatigue documented in MS individuals2 1 •37 •39 may improve with a 
long term LFES program by modifying the expression of muscle contractile 
characteristics from that of fast twitch to that of slow twitch. The decreased 
strength in muscles of individuals with MS36'3 8 '5 8  may demonstrate an increase in 
strength due to the training stimulus imposed by the electrical stimulation at a 
comfortable delivery frequency. 
Consideration should also be given to whether the pathological process 
involved in MS makes it a viable candidate for the benefits induced by a LFES 
program. LFES research has demonstrated positive results in subjects with 
muscular dystrophy. In muscular dystrophy, the primary pathological process is in 
the muscle tissue itself and consists of a replacement of healthy muscle fibers with 
connective and adipose tissue. Muscle biopsy has not demonstrated selective 
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atrophy or hypertrophy of a fiber type, but Type I fiber predominance is 
common. 59 The neural supply to the muscle is not affected in muscular dystrophy. 
A case could be made that the changes induced by LFES might be able to offset 
the muscle deterioration of the disease, and still have the support of an intact 
neural system. Most likely this type of premise has encouraged research in this 
area; however, the physiological changes proven to occur in normal muscle tissue 
due to electrical stimulation may not be transferable to the diseased muscle in 
muscular dystrophy. 
Conversely in MS the muscle tissue is normal, but the neurological impulses 
from the CNS are disrupted as a part of the pathological process. It may be less 
tenuous to apply the documented changes seen in healthy muscles due to LFES to 
the ''normal" muscle tissue of individuals with MS. This of course does not 
negate any CNS deficit that may be present, but two principles regarding MS 
should be noted. First, CNS lesions in MS can be spotty such that only part of the 
neurological supply to any one muscle may be affected. There could still be 
sufficient innervation intact to support some functioning of the muscle. Low 
frequency stimulation may be able to maximize the remaining functional potential 
of the muscle. Second, MS can be typified by remissions and exacerbations. Low 
frequency stimulation may be able to fill a specific niche in the rehabilitation 
process after an exacerbation by increasing the strength or functional use of a 
muscle left weakened by the exacerbation. Ideally, this could be done until 
volitional exercise could be initiated. 
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The purpose of this study is to evaluate the effects of a LFES program on 
individuals with MS. This will be done by assessing changes in the muscle's 
volitional strength and endurance in response to the protocol administered. It is 
hoped that information leading to the viability of this treatment alternative for 





With the approval of the local chapter of the National Multiple Sclerosis 
Society, individuals with multiple sclerosis were recruited as potential subjects 
through local multiple sclerosis support group meetings. All individuals 
expressing an interest in participating in the study underwent an initial patient 
history and general functional evaluation by the investigator. A standardized form 
was followed for all individuals (Appendix, pp. 85, 86). This assessment helped 
to discover any possible medical contraindications to the electrical stimulation 
device and determined the appropriate physician to be contacted for study 
participation. It also documented the type and frequency of symptoms associated 
with MS, and the medicines prescribed to treat these symptoms, which provided a 
basis for assessing changes that may occur during and after the experimental 
treatment intervention. 
After the initial history and evaluation, information letters were sent to each 
potential subject's physician (Appendix, p. 87). Also included was a permission 
form for each subject to be signed by the physician (Appendix, p. 88). Acceptance 
into the study was contingent upon physician approval. 
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Of 14 individuals expressing a desire to participate in the study, nine met all 
the qualifying criteria and were admitted as subjects. Of the other five people, 
two were disqualified due to medical problems, two were not allowed to 
participate by their physician (the physician was the same for these two 
individuals), and one lacked a definitive diagnosis of MS. 
The subjects represented a continuum of possible functional disability due to 
MS. They ranged from being independently ambulatory and employed full-time to 
requiring maximal assistance for all mobility and personal care. Overall, six of the 
nine subjects were ambulatory, including those who utilized an assistive device 
such as a standard or quad cane. None of the subjects had recently begun any 
exercise program or physical therapy treatment, and all subjects were asked to 
refrain from beginning any new exercise programs or therapy during the course of 
the study. 
The subjects consisted of six females and three males, ranging in age from 3 0  
years to 64 years ( average age, 46 years; median age, 46 years). The years since 
disease diagnosis ranged from 3 years to 20 years (average, 8 1/2 years; median, 8 
years). Six of the nine subjects considered their disease classification as the 
chronic progressive form, while the other three reported having remissions and 
exacerbations. The most recent onset of an exacerbation was 4 1/2 months prior 
to the beginning of the study. The number of prescription medications for each 
subject varied from zero to nine. The most recent introduction of any new 
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medicine was approximately 3 weeks prior to study onset. Of the nine subjects, 
only one was currently on the newly marketed beta seron drug. 
Procedure 
General: All subjects read and signed an informed consent document 
(Appendix pp. 89, 90) prior to any testing. Each subject was first seen in the 
clinic to obtain initial strength and endurance measurements· of both quadriceps 
femoris muscles. This was followed by the application of the portable 
neuromuscular electrical stimulator to be used at home for 6 weeks on the 
quadriceps muscle designated as the experimental leg. Following the 6 weeks of 
home stimulation, each subject returned to the clinic for final assessment of both 
quadriceps femoris muscles' strength and endurance. Strength and· endurance 
measurements were performed on an isokinetic dynamometer (Cybex II). 
Calibration of the machine was performed before the initial testing sessions and 
prior to the final testing sessions in accordance with the Cybex Systems 
Handbook. 
Pre-treatment Testing: Each subject was scheduled for two initial testing 
sessions in the clinic separated by 4 days or less. In each session, the same muscle 
testing procedure was followed. This dual testing format_ is in accordance with 
the suggestion of Armstrong et al. 36 Their research indicated that a 
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familiarization session reduced the variability in isokinetic dynamometry 
measurements due to extraneous factors in subjects with MS. 
In the first testing session of the first subject scheduled, a coin flip determined 
whether the right or left leg would be tested first on that subject. For each 
subsequent subject, alternating right and left legs were tested first. 
Subjects were seated on the Cybex II isokinetic dynamometer so that the 
appropriate leg could be tested first. A testing data sheet (Appendix, p. 9 1) was 
used to record the date, time, temperature, and calibration date of each testing 
session, and to annotate the necessary Cybex settings to ensure accurate 
replication on post-testing. This form also provided a checklist for maintaining 
standardization across all testing sessions. Subjects were seated on the Cybex 
bench utilizing one back support pad. Similar to the testing procedure of 
Armstrong et al. 36 with MS subjects, the mid-point of the lever arm head was 
aligned with the axis of knee rotation. The lever arm length was adjusted so that 
the bottom part of the ankle pad was level with the superior border of the lateral 
malleolus. Extraneous movement was minimized by securing each subject with a 
lap belt, knee belt, and an ankle strap. The appropriate Cybex settings for 
damping, clockwise/counterclockwise, and foot-pounds scale were selected and 
recorded before testing each leg. 
Each subject performed three warm-up submaximal isometric knee extension 
contractions with the chart paper speed on 5 mm/sec. During these contractions, 
the proper operation of the Cybex was assured as well as the comfort of the 
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restraints and lever arms. After a 2-minute rest, each subject performed three 
maximal isometric knee extension contractions with a 5-second hold, again with 
the chart speed on 5mm/sec and 2-minute rest between each maximal contraction. 
For each maximal isometric contraction, the subject was instructed to put their 
hands across their lap, and on the tester's count, to ''push up with your foot as 
hard as you can and keep pushing until I say 'relax"'. The subject then switched 
seating positions on the Cybex bench so that the same procedure could be done to 
the opposite leg. 
The first testing session of the pre-treatment testing was done prior to 
applying the experimental stimulation device to allow for a quantification of the 
strength differences between the two quadriceps femoris muscles of each subject. 
This information was used in the second session of the pre-treatment testing to 
select which quadriceps muscle would receive the neuromuscular electrical 
stimulation. Starting with the first subject in the second session of pre-treatment 
testing, a coin flip determined whether the weaker or stronger leg would receive 
the electrical stimulation for that subject. Subsequently, weaker or stronger legs 
were alternately chosen to receive the neuromuscular stimulation on all of the 
following subjects. One exception was made for a subject who needed to wear 
the stimulator on a specific leg due to a catheter bag on the opposite thigh. 
Neuromuscular Electrical Stimulation: The Respond Select TM neuromuscular 
stimulator was chosen to deliver the low frequency electrical stimulation because 
42 
the desired electrical stimulation parameters could be programmed into the 
machine. This stimulator is compact in size (6.0 inches x 3. 5 8  inches x 1. 37 
inches) and relatively lightweight (7.6 ounces without batteries). The electrical 
stimulation parameters desired for the 6-week home protocol were pre­
programmed by the investigator. A symmetrical biphasic square wave, with 300 
microseconds phase duration, was delivered at a frequency of 8 pps. The on-time 
of the stimulation was 5 5 seconds and the off-time was 2 seconds. The time 
required for the phase to reach peak amplitude (rise time) was 5 seconds . 
After completing the second session of the pre-treatment testing, the portable 
stimulator was applied to the experimental leg. This was done in the clinic and 
with the subject on the Cybex machine in hopes that the force output of the 
experimental leg could be measured and quantified in response to the electrical 
stimulation from the portable device. 
Four re-useable electrode pads were placed on the experimental quadriceps 
muscle. Guidelines for positioning of electrodes were derived from a- motor point 
chart (Appendix, p. 92) with minor individual adjustments made to maximize · 
muscle contraction and minimize subject discomfort. Intensity of the stimulus was 
increased very gradually and limited by subject tolerance. Once a subject felt the 
maximum tolerable level had been reached, an effort was made to quantify the 
intensity of the stimulus by its force readout on the Cybex. 
Each subject received detailed instruction in the proper operation and care of 
the stimulator, and a Stimulation Progression Sheet and Time Log (Appendix, p. 
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93, 94 ). This form guided the subject in increasing the daily stimulation time. 
The first day each of the two stimulation sessions lasted 15  minutes. Stimulation 
time was increased 15  minutes per session each consecutive day until a duration of 
I 1 /2 hours for each session had been obtained. 
Subjects were instructed to increase the stimulation intensity after having 
plateaued at I 1 /2 hours stimulation duration. The researcher encouraged each 
subject to adjust the stimulation intensity to a level which provided the strongest 
visible contraction of the muscle while still being a tolerable sensation for the 
individual. The time log provided space for recording clock time and dial setting 
for each session, as well as room for daily and weekly comments. In an effort to 
accommodate individual daily schedules, there was no specific time required to 
separate the two daily sessions, nor was one specific day required to be the off 
day for all subjects. 
During the following 6 weeks, each subject wore the portable stimulator while 
continuing with their normal daily activity. Subjects were visited weekly at their 
home, or place of employment, during this 6-week period. New electrode pads 
were provided and changed approximately every 1 0  days. At each visit, time logs 
were checked for completion, and the desired settings were confirmed on the 
portable stimulator. Proper placement of electrodes was also covered, and when 
possible, electrode pads were applied by the investigator at the time of the visit. 
Individual charts were maintained on each subject by the investigator documenting 
the activities of each visit and any other communication with the subject. 
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Post-treatment Testing: After 6 weeks of stimulation, subjects were scheduled 
for two separate clinic visits to repeat the testing of both quadriceps muscles on 
the Cybex. As in the pre-treatment testing sessions, three warm-up submaximal 
contractions followed by .three maximum isometric knee extension contractions 
with a 5-second hold were performed. Cybex settings recorded in the pre­
treatment sessions were duplicated for post-treatment testing, and the same 
testing protocol was followed as discussed in the pre-treatment testing. The time 
of day of testing for the final session was the same as the pre-treatment testing 
session. 
The intensity of the electrical stimulation tolerated from the portable 
stimulator was re-assessed for each subject in post-treatment testing. This was 
done by obtaining a force readout on the Cybex of the muscle contraction elicited 
by the portable stimulator. Each subject was instructed to increase the intensity 
of the stimulation to a level which caused a muscle contraction commensurate 
with the strength of the muscle contraction they had been performing at home. All 
subjects used the portable stimulator until the day of the second session of post­
treatment testing, but not the day of the second session post-treatment testing. 
A follow-up questionnaire regarding the electrical stimulation protocol was 
mailed approximately 2 weeks after the study' s completion to determine the 
subjective responses of the subjects to the protocol (Appendix, p. 95, 96). 
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Statistical Analysis: Each maximal isometric contraction with a 5-second hold 
yielded three indices of muscle performance: peak torque, mean force, and fatigue 
slope. Peak torque was the highest torque obtained in the contraction and was 
designated fp on the Cybex graph, occurring at time of peak torque, tp. Mean 
force was the arithmetic average of force from the time of peak torque (tp) to the 
end of the 5-second hold (ts) inclusive, with force readings taken every .5 
seconds. The next to the last force reading taken for averaging was no less than 
.2 seconds from ts. Fatigue slope was calculated according to the following 
formula : 
Fs = 
fi, • f, X 100 
fp 
In this formula, fatigue slope is Fs and is expressed in %/sec units; fp is the 
peak force; f5 is the force at 5 seconds; ts is the 5-second time mark; and, tp is the 
time of peak torque. All Cybex readouts were initially in foot-pounds and 
converted to newton-meters. 
The average of each of the above three indicators was computed from the 
three maximum isometric contractions giving the dependent variables of average 
· peak torque (APT), average mean force (AMF), and average fatigue slope (AFS). 
Utilizing the data from the second session of the pre-treatment testing, the 
experimental legs and the control legs were compared in an analysis of variance 
(ANOV A) with one within subject variable to ascertain the similarity of the two 
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groups. The data from the second sessions of the pre-treatment and post­
treatment testing were used in the statistical analysis for determining the effects of 
the treatment. For each dependent variable, a two-way ANOVA with two within 
subject factors was performed. The within subject factors were time, represented 
by two levels of pre- and post-test results, and group, representative of the two 
levels of either the control or experimental leg. The null hypothesis was that the 
LFES would not cause a significant change in these three variables over time for 





The ANOV AS comparing the initial values of the dependent variables average 
peak torque (APT), average mean force (AMF), and average fatigue slope (AFS) 
for the experimental legs compared to the control legs are displayed in the 
Appendix (p . 97). Prior to the application of the electrical stimulation program, 
experimental and control legs were not statistically different for APT (p < . 6365), 
AMF (p < .  75 62), or AFS (p < . 4732). 
Table I shows the increase(+) or decrease(- ) in the experimental and control 
legs for each of the three dependent variables. From this table, the variability in 
response to the LFES is easily recognized. Subjects one, two, three, and five each 
demonstrated a different response pattern for the experimental and control leg on 
the measures of peak torque and mean force. In contrast, for fatigue slope most 
subjects demonstrated a decrease in muscle fatigability for both the experimental 
and the control leg . The raw data is also available for inspection in the Appendix 
(p . 98). 
The ANOV A summary tables for treatment effects of all three dependent 
variables, and the simple effects for AMF, are found in the Appendix (pp . 99, 
1 00). APT did not reveal statistical significance at the .05  probability level for 
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Table 1 .  Increase(+) or Decrease(-) in Experimental vs Control Leg 
Avg Peak Torque . Avg Mean Force Avg Fatigue Slope 
( change in Nm) (change in Nm) ( chanJ?; e in %/sec) 
Exp Control Exp Control Exp Control 
Sub.iect 1 -6. 3 -6. 32 -2. 29 -5. 12 -5.53 - . 1 1  
-3 . 85 +2. 49 -. 18 +3 . 14 - 1.66 -. 33  
+9. 72 +6. 13  + 10.49 +9.07 - 1.44 -4. 24 
+ 12.03 +. l + 12.08 +4. 3 1 - 1.05 -4. 39 
+8.92 -5.65 +7.46 -5.48 + 1. 1 7  3 .27 
+3 8. 19 +13.56 +33 .93 + 1 1.55 -5. 84 -2.06 
+5. 38  + 12. 89 +5. 44 +12. 83 -. 3 8  -.02 
+4.43 +2.52 +4.25 +2 .63 -3.5  -5.68 
+28.92 + 1 1.97 +26.66 + 12. 12 +.92 -1 . 78 
either time (p< .0566), group (p < . 8390), or time/group interaction (p < . 1073). 
However, inspection of the graph of the interaction in Figure 1 suggests a possible 
trend for increasing peak torque for the experimental group above that of the 
control group. 
AMF statistical significance occurred for time (p < . 025 1 ), but not for group 
(p < .9635), or time/group interaction (p < .0985). As for APT, graphing of the 
time/group interaction for AMF (Figure 2) demonstrates the interplay of time and 
group suggesting a greater increase in mean force for the experimental leg than 
the control leg. Simple effects demonstrated significance of time on the 
experimental leg (p < .027), but not for the control leg (p < .065) (Appendix, 
p . 100 ). For both APT and AMF, the large standard error of the mean ( SEM) bars 
depicted on the graphs also show th� variability in subject response. 
Six out of nine subjects increased the APT and AMF on both the experimental 
















Figure 1 .  Interaction of time and group for Peak Torque 










with standard error of mean bars. 
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Figure 2. Interaction of time and group for Mean Force 
with standard error of mean bars. 
experimental leg. The average increase in APT for experimental and control legs 
was 37. 59% and 1 9 .48%, respectively. The average increase in AMF was 39 .99% 
for the experimental leg and 26. 73 % for the control leg. 
The dependent variable average fatigue slope was significant for time 
(p<.0348), but not for group (p < . 3325) or interaction effects (p < . 83 8 1 ) . The 
graphic depiction in Figure 3 demonstrates a decrease in fatigue slope for both 
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experimental and control legs. The SEM bars indicate wide subject response 







Figure 3. Response of time and group for Fatigue Slope 
with standard error of mean bars. 
The stimulation intensity tolerated by the subjects increased during the six 
weeks that the stimulation was used. During pre-treatment testing, six out of nine 
subjects were either unable to elicit a measurable contraction on the Cybex 
induced by the portable stimulator, or the force readout on the Cybex was less 
than 1 % of the average maximum voluntary isometric contraction (MVIC) 
measured for that subject. At pre-treatment testing, the range of muscle force 
produced by the portable stimulator ranged from O to 4.53% MVIC with an 
average of . 83% MVIC. 
At post-treatment testing after 6 weeks of stimulation, only one of the nine 
subjects produced a muscle contraction force less than 1 % MVIC in response to 
the portable stimulator. One subject was considered an outlier eliciting a 
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contraction that was 137. 66% of MVIC. Disregarding this person's data, the 
range at final testing was .53% to 18.22% MVIC, with an average of 6.42% 
MVIC, demonstrating a good increase in stimulation intensity tolerance. 
In summary, as a result of the statistical analysis using the pre-determined . 05 
probability level for significance, the decision is to not reject the null hypothesis 
that this LFES program has no effect on the strength and endurance of the 




In discussing the outcomes of this study, consideration will be given to the 
clinical trials nature of the research design followed by an in depth assessement of 
the statistical results for each of the three dependent variables, including the 
conclusions which can be drawn in reference to the initial research question. The 
results of the exploration of the data for possible response patterns will also be 
covered. 
Clinical Trials Nature of the Study 
The clinical nature of this study provided a framework for planning the 
research protocol, and its influence should be considered when the results of this 
study are assessed. A main objective of the study was to examine a clinical 
treatment protocol in a specific patient population under "real world" conditions. 
This goal of the study molded aspects of the research design specifically in 
regards to the selection process for subjects, and the decisions of which indices of 
performance would be used. The clinical trials nature of this study also allowed 
the inclusion of numerous extraneous variables for which experimental control 
could not be enforced. In the following section, the clinical trial aspect of the 
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study as it relates to components of the research design, including the extraneous 
variables of the study, will be discussed. The influence this exerted on selecting 
the appropriate statistical analysis will also be considered. 
Research Design Aspects: The objective of this study was to examine the effects 
of a LFES program in a clinical population. This permitted subject selection to 
include individuals with multiple sclerosis which represented a broad range of 
functional disability. Although previous studies involving multiple sclerosis 
limited subject selection to ambulatory subjects, 3 6'39 by the inclusion of a wider 
span of subject functional levels, not only would this increase the external validity, 
but also it would allow for the revelation of any response patterns. Trends in 
responses were inspected for their correlation with certain subject traits, such as 
initial strength level, or stimulation intensity tolerated, and will be discussed later 
in 'Exploration of the Data '. 
One objective of the research design was to obtain the most valid 
representation of each individual 's muscle performance at each testing session. 
To accomplish this, the responses of each variable across the three contractions 
were averaged, for this may provide a more true and consistent indicator of 
individual performance. This . is particularly applicable for subjects with a disease 
typified by variation. The unfamiliarity of the subjects with testing equipment 
such as the Cybex also supports averaging of responses. 
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The decision of what indices to use for representing muscle strength and 
endurance was also guided by clinical practicality and applicability. The maximum 
voluntary isometric contraction has been commonly used as an indicator of muscle 
strength on healthy subjects, 60'6 1  and for subjects with pathologies. 1 6 •20•39 
Quantifying the muscle's endurance capability is more elusive. As noted in the 
literature review, many studies investigating the effects of a low frequency 
electrical stimulation program on animals and humans have taken the muscle's 
force decrease in response to a train of electrical impulses at 40 Hz as an indicator 
of the muscle's endurance. 1 6' 1 7 '2 1 '3 1  However, as noted by D. S. Stokic, MD, a 
researcher at Baylor College of Medicine in Houston, Texas, (verbal 
communication, February 1994), published studies have yet to prove that 
electrically induced fatigue has any correlation to the volitional performance of 
the muscle. In terms of performance criteria, Gehlsen et al. 39 quantified endurance 
in the quadriceps muscle of MS individuals by calculating the percentage of peak 
torque decline that occurred in 50 isotonic knee extension/flexion contractions at 
180 degrees/second on the Cybex. This methodology provides a good indicator of 
performance fatigue; however, this level of physical activity exceeded the 
capability of several of the subjects in this study, and of many other patients that 
might be encountered in a clinical setting. Chen et al. 37 also assessed muscle 
endurance in individuals with multiple sclerosis by using a voluntary isometric 
knee extension contraction with a 5-second hold. Endurance was represented by 
the tension-maintaining capacity (TMC) of the muscle. This was calculated by 
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counting the squares in the area under the torque curve of the Cybex printout. 
Although this procedure could be applied to all subjects in this study, in practice, 
this technique does not always provide a consistent indicator of muscle endurance. 
A Cybex curve with an extremely high initial peak torque, but one which drops off 
rapidly, could easily give a higher TMC score than a curve which maintained a 
consistent force across the 5-second hold. The initial height of the curve could 
encompass more squares than that which would be included in a consistent, 
maintained force read out. 
To overcome some of the above problems, three indices of performance were 
decided upon which were derived from the Wingate Anaerobic Test. 62•63 The 
measurement of peak torque is similar to Wingate's peak power index and is taken 
to represent the maximum strength capability of the muscle. The Wingate test 
utilizes a "rate of fatigue" or the slope of the line from the highest to lowest 
torque. In this study, the fatigue slope index is calculated to represent the overall 
rate of force decline from peak torque to the torque produced at the 5-second 
mark. It is considered a measurement of muscle endurance. Lastly, the mean 
force of the quadriceps muscle is the arithmetic average of force produced over 
the 5-second hold in the maximum isometric knee extension contraction. This 
measurement equates to the mean power index of the Wingate 30-second test. In 
this study, the mean force measurement is considered to represent a combination 
of the functional strength and endurance of the muscle. All three indices can be 
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obtained from an isokinetic graph print-out, which makes this assessment 
technique readily accessible to most clinicians. 
Determining which index, mean force or fatigue slope, constitutes a better 
representation of the muscle 's endurance performance is debatable. The fatigue 
slope gives an overall picture of the force decrement in the muscle for the 5-
second hold. However, in disease processes like multiple sclerosis, which is 
typified by a fluctuating force response on the Cybex, 37 calculating the mean force 
with force readouts every . 5 seconds may provide a better indicator of the 
muscle 's endurance, and be more sensitive to changes in endurance in response to 
a treatment. 
Extraneous Variables: The clinical trials nature of the study also allowed 
several uncontrolled variables to be present in the study. Some of these variables 
were tied to the methodology of treatment implementation such as subject 
compliance, motivation, and seasonal changes in strength. Others were related to 
the varied functional levels of the subjects, to fluctuations inherent in the disease 
process of MS, and to medications taken by the subjects. 
One of the most common sources for variation in a home program revolves 
around subject compliance to the program. Each subject completed a daily log 
which indicated exceptional compliance. The Respond Select portable stimulator 
is equipped with a time compliance feature which allowed the investigator to 
monitor how much the machine had been used. However, the information 
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provided tells only the hours of operation for the machine since the device was 
last zeroed. It cannot be determined whether the machine was actually applied to 
the body or simply turned on. Moreover, it cannot judge whether the device was 
correctly applied to the body by the subject, or to the appropriate part of the 
body. It does however provide some insight into the actual usage time as 
compared to reported time, since the retrieval of this information is not readily 
apparent to the subject .  
To assist in confirming that changes in the muscle were due to the treatment, 
periodic checks of the timer function were annotated and compared with the time 
requirement of the daily log. Inspection of this information indicated 1 00% 
compliance in five subjects. Compliance for the other four subjects was 9 1  %, 
73%, 66%, and 6 5%, resulting in an overall compliance average of 88%. The data 
results for the two subjects with the two lowest compliance times did not 
represent any substantial trend differences from the other subjects. It is important 
to realize that the information was not collected with the accuracy suitable for 
statistical analysis, but only for the purposes of establishing general trends. The 
information provided by the stimulator, in conjunction with the apparent 
motivation of the subjects, suggests that compliance was good overall. 
Subject motivation played another role in the study due to the obvious nature 
of the treatment program, and its interaction with the dedication of the subjects to 
find a beneficial treatment option. The primary reason expressed by each subject 
for participating in the study was the desire to help themselves and possibly other 
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people with MS. This, combined with the conspicuous nature of the treatment 
application, necessitates the inclusion of a possible Hawthorne effect in the results 
of post-treatment testing. 
Another confounding variable relates to the time of year in which this study 
spanned. The 6 weeks from pre-test to post-test transpired from mid-spring to 
early summer and coincided with a general trend for increased physical activity 
among several of the subjects. The increased activity could cause an improvement 
in muscle contractile characteristics not due to the electrical stimulation program. 
This may explain why six out of nine of the subjects had increases in average peak 
torque and average mean force on both experimental and control legs. Also, the 
subjects which were more active and who became busier with the improving 
weather, reported having more difficulty finding the time to do the 3 hours a day 
of electrical stimulation. Initially, there was concern that warming temperatures 
may adversely effect the post-treatment measurements due to the heat intolerance 
often experienced by individuals with MS. This prompted the recording of inside 
and outside temperatures at pre- and post-treatment sessions. In actuality, 
subjects did not feel that the increased outside temperature resulted in poorer 
post-treatment performance, as adequate rest time in an air conditioned 
environment was provided. 
Uncontrolled sources of variation also resulted due to the subjects having a 
ongoing disease process. The erratic disease progression and individual variation 
in symptoms due to MS pose a particular challenge for research design. As 
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expected, individuals in transition from a remission or exacerbation make 
assessment of treatment changes difficult ; but the more subtle and persistent 
fluctuations in daily, or even hourly performance, present as much of a problem in 
evaluating outcomes. Details such as time of day of the testing, testing 
temperatures, and previous activity the day of testing, can probably be more 
influential in affecting the performance response of subjects with MS than 
"healthy normal" subjects. 
It is not surprising that each subject had different tolerance levels for the 
electrical stimulation intensity; however, one subject 's ability to tolerate the same 
stimulation level was markedly altered during the study' s course. This subject 
reported an increasing sensitivity and unpleasant sensation from the stimulation 
during the fourth to sixth week of the stimulation program. Commensurate 
decreases in functional ability, and increases in muscle spasticity, motivated the 
subject to request advice from her physician. Although a causal relationship can 
not be known for certain, the alteration in sensitivity occurred in conjunction with 
a progressive imbalance in the subject's magnesium, potassium, and calcium, 
which was detected by this medical evaluation. The biochemical alteration was 
considered most likely to be secondary to a medication being taken. 
Medications taken for controlling symptoms associated with MS may also 
contribute a great deal to uncontrolled variation in this type of research. In the 
present study the number of prescribed medications taken by subjects ranged from 
zero to nine. Although acceptance into the study prohibited having just started 
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any new medication, adjustments to doses, or pharmacological treatment of 
specific problems during the study, could not be obviated. One subject required 
an increase in anti-spasticity medicine, while another required five days of 
intravenous cortisone therapy to improve a decline in visual acuity. Both of these 
instances represent the need for continual adjustment in the medical treatment 
required to meet the ever changing physical and physiological state imposed on 
the body as a result of MS. This type of variation can not be reasonably 
controlled in either a research scenario or a clinical environment. 
Selection of Statistical Procedure: All of the above extraneous variables 
contribute to form tremendous between-subject and within-subject variability. 
The desired statistical procedure needed to be able to control for changes within 
each subject, such as fluctuations in performance and changes in medications, and 
to avoid the inflated significance which may occur if multiple paired t-test 
comparisons are used. The methodology considered to be most sensitive in 
extricating the changes in muscle characteristics attributable solely to the low 
frequency electrical stimulation program was an analysis of variance with two 
within subject variables. 
From the foregoing discussion, the clinical nature of the research design has 
been considered for its impact on the study's methodology, and on the selection of 
the statistical procedure. It will be considered further in the following section for 
its relationship to the statistical results of the dependent variables. 
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Assessment of Statistical Results 
The results of this study did not conclusively demonstrate the muscle 
performance changes that were expected as a result of a LFES program. In 
contrast to the findings of much of the previous research, statistical significance at 
.05 was not achieved for the indicators of muscle strength, average peak torque 
(APT) and average mean force (AMF), or for the indicator of muscle fatigue, 
average fatigue slope (AFS). Possible reasons for this are discussed below. 
APT and AMF: Both of these variables came close to the pre-determined 
significance level of .05 demonstrating a possible interaction between time and 
group (APT, p<. 1073 ; AMF, p<.0985). Two factors in this study may have 
limited the complete expression of this trend of increasing strength for the 
experimental leg. 
The first factor relates to the 6-week duration of the treatment application. 
Pette et al. 8 and Rubenstein et al. 1 0  emphasized the incomplete nature of the 
conversion of muscle traits from fast to slow twitch in the predominantly fast 
twitch muscles of rabbit. The degree of changes was related to the length and 
duration of the stimulation program. In animal models demonstrating changes in 
muscle enzyme activity and contractile characteristics, stimulation frequencies of 
8- 10 Hz were generally delivered 8 to 10 hours a day for at least 3 weeks before 
initial changes were documented in the muscle properties. 1 •8 •1 0 •43'46 It may be that 
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in human subjects, when the daily stimulation time is reduced to 3 hours a day, a 
longer than 6-week duration is needed to produce the same contractile changes in 
the muscle. The 6 weeks of this study may not have been sufficient for permitting 
these changes to be expressed. The trend toward increasing mean force over time 
for the experimental leg supports the contention that a longer program may have 
demonstrated statistically significant changes on this measure. 
The second factor, and probably the most influential, relates to the clinical 
trials nature of the research design. As discussed earlier, this incorporated many 
extraneous variables into the study and made obtaining statistical significance at 
.05 with a subject number of nine very difficult. According to the equations and 
tables set forth by Kraemer and Thiemann, 64 for nine subjects with the critical 
effect size present in this study, only a 40% chance of detecting a significant 
change existed for a two-tailed test at .05 significance level. For this reason, the 
results of this study may warrant a more generous approach than that allowed by a 
pre-determined . 05 alpha level. 
Franks and Huck65 make a strong argument for using significance levels of . I 0 
or greater in studies which meet certain research criteria. Studies that are 
exploratory in nature and that employ a small subject number are encouraged to 
use significance levels higher than the traditional cap of .05. Both of these 
criteria are contained in the present study. Further, Franks and Huck specify the 
use of a higher alpha level to be particularly appropriate when the consequences 
of a Type II error can be considered more costly than that of a Type I error. A 
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Type II error in this study would mean accepting the null hypothesis that electrical 
stimulation has no effect on muscle strength or endurance in multiple sclerosis 
patients, when in fact, it does have an effect. The consequences of such an 
erroneous acceptance could deprive a patient population from having a viable 
treatment option uncovered through future research. This could be considered 
costly. Conversely, a Type I error in this study would represent erroneously 
· rejecting the null hypothesis, i.e. , claiming that LFES does affect muscle strength 
or endurance in MS subjects, when in fact, it does not. Since the safety and 
comfort of LFES has been well established and does not include any negative side 
effects, the consequences to the subjects of such a Type I error are minimal 
enough to permit further investigation within the limits of reasonable cost and 
time. However, care must also be taken not to instill false hopes in individuals 
with MS if subsequent investigations also prove negative. For this preliminary 
investigation, the conditions set forth by Franks and Huck apply allowing the 
statistical results of this study to merit evaluation with a higher significance level 
of .10 or .15. Statistical significance would then encompass the time and group 
interaction for the dependent variables, average peak torque and average mean 
force. 
AFS: Unlike the approaching significance for peak torque and mean force, the 
statistical result for fatigue slope on the interaction of time and group was far 
from obtaining significance (p<. 83 81 ). However, being so far from statistical 
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significance may divulge information just as important as coming close to 
significance. 
The results of muscle fatigability of this study being so divergent from 
previous studies may relate to methodological differences. In the previous 
research muscle contractile changes of twitch: tetanus ratio and half-relaxation 
time, along with muscle fatigue, were ascertained by electrical stimulation testing 
procedures. Changes in contractile properties and muscle fatigue usually occurred 
simultaneously. In the present study muscle fatigue was measured by volitional 
performance criteria. Research has yet to prove that changes in muscle contractile 
pr�perties or fatigue detected by electrical stimulation testing have any correlation 
with changes in muscle fatigue detected by volitional performance testing. This 
leads to the possibility that changes in volitional muscle performance are a distinct 
entity from electrically detected changes, and may occur elsewhere along the time 
course of changes due to LFES. Pette 1 9  reported that enzymatic and contractile 
changes in muscle happen in conjunction with each other and precede changes in 
myosin light forms and histological fiber type. As discussed previously, fatigue 
resistance to tetanic contraction is often considered as a corollary to muscle 
contractile changes. Although this study used the 6-week stimulation protocol of 
Gauthier et al. 22 which demonstrated enzymatic changes, changes in muscle 
contractile properties can only be assumed since they were not tested. 
Performance changes, however, may require a longer duration of stimulation to be 
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expressed and may only occur concommitantly with the later changes in myosin 
light forms and histological fiber type. 
It is also interesting to note that the fatigue slope decreased similarly in the 
experimental and the control leg. This could be the result of a cross-over effect 
with the electrical stimulation. The cross-over effect, or cross-training effect, 
contends that muscle changes may also occur in the opposite unstimulated limb as 
a result of the stimulation of the experimental leg. This concept is debated in the 
literature. Scott et al. 3 1  suggest a possible carry-over effect from the stimulation 
in their subjects with muscular dystrophy; however, many studies have reported 
no muscle contractile changes in the contralateral leg in response to a LFES 
program. 15 • 1 7 •20 The general consensus from previous research is that, if present, 
the cross-training effect is very minimal. However, these studies used the 
electrical stimulation testing methods previously discussed, and based their 
conclusions regarding cross-training on the data obtained in that manner. It is 
quite possible that the emergence of a cross-training effect becomes more readily 
apparent when volitional performance testing methods are used as in the present 
study . In subjects with central nervous system lesions ( as in MS), motor learning 
may be a factor in the contralateral limb due to stimulation on the experimental 
leg. 
Conclusions Regarding the Research Question: The traditional manner of 
assessing the value of statistical results is by using the pre-determined critical 
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significance level as a dividing line between what is meaningful and what is not. 
However, this approach may not always address all levels of the study' s results 
which deserve consideration. This gray area of determining significance and non­
significance is described by Moore and McCabe66 as follows: 
Making a decision is different in spirit from testing 
significance, though the two are often mixed in 
practice. Choosing a level alpha in advance makes 
sense if you must make a decision, but not if you wish 
only to describe the strength of your evidence. 
In clinical research of the exploratory type, consideration of the statistical 
results for possible trends becomes as important as the "critical" significance level 
for discerning what may represent meaningful information. Areas to be considered 
for future research may be indicated by trends in the data analysis. In this study, 
the interaction of time and group factors for the variables average peak torque 
and average mean force strongly suggest a possible meaningful interplay between 
these two factors. As presented in the 'Results' section of this paper, graphs of 
this interaction show the trend of increasing peak torque and increasing mean 
force over the 6-week stimulation time for the experimental legs versus the 
control legs. Inspection and consideration of this information provides a 
foundation for future research, possibly involving a greater number of subjects or 
a longer stimulation duration in the protocol. 
Even if .05 is heralded as the necessary 'critical ' level for discerning 
significance versus non-significance, the distinction between "failing to reject" and 
"accepting" a null hypothesis is still a worthy concept. Accepting a null hypothesis 
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based on an alpha level of . 05 incurs a fairly high chance of making the Type II 
error of accepting a false null hypothesis. 67 The cost of this decision has been 
outlined above in the discussion for a more generous interpretation of the data. In 
contradistinction to this, failing to reject the null hypothesis means only that the 
results of a study do not substantiate completely disregarding the null hypothesis. 
In this study, at the . 05 significance level, the results preclude rejecting the null 
hypothesis and accepting that the LFES program makes a significant difference in 
muscle strength and endurance; however, the results do not force accepting the 
null hypothesis with the alternative conclusion that LFES has no effect. Instead, 
the decision of failing to reject the null hypothesis recognizes that future research 
may better clarify the effects of a LFES program on individuals with MS. As 
cited above, this decision is permissible on a limited basis since the consequences 
of a Type I error are minimal. 
In the previous section, the statistical results for the dependent variables have 
been inspected with possible explanations for these results presented. Information 
can also be derived from an exploration of the data. 
Exploration of the Data 
A further objective in this study was to be alert for response trends in regards 
to certain traits or characteristics. One method to search for response patterns in 
the stimulated muscle is to examine changes in the experimental muscle as it 
differs from the control. In order to compare one subject to another, the percent 
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change for each variable for the control and experimental legs were compared to 
formulate a new index of percent change for the experimental leg. This adjusted 
index describes the degree of change in the experimental leg while accounting for 
the change which also occurred in the control leg. As an example, for subject 
number two, the APT of the control leg increased 2 .  69% while that of the 
experimental leg decreased 3 . 48%. Accounting for the increase in the control leg, 
the real decrease in strength of the experimental would be a larger 6. 17%. 
Adjusted values for each of the three dependent variables, APT, AMF, and 
AFS, were examined for response patterns. Previous research has suggested that 
differing responses may occur in relation to the initial strength of the muscle being 
stimulated. Speculation of response differences due to the stimulation intensity 
tolerated by the subject has been a concern as well. To examine strength levels 
across subjects, each subject's initial MVIC was taken as a percent of that 
subject 's body weight and arranged by increasing strength . The corresponding 
adjusted values for APT, AMF, and AFS were inspected for trends. A similar 
continuum was created based on the intensity of the stimulation used by the 
subject. The force values elicited by the portable stimulator at the post-treatment 
testing session were expressed as a percentage of each subjects MVIC and ranked 
with the corresponding adjusted values for each dependent variable. 
Inspection of the data as graphed in Figure 4 does not demonstrate any 
response trends for the initial strength on any of the three variables. Although the 
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Figure 4. Change in APT, AMF, and AFS as a Function of Initial Strength 
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the end ranges of initial strength shows only minimal deviation from the zero line 
for APT, AMF, and AFS. The greater changes in peak torque and mean force 
corresponding to a lower initial strength as seen in the second graphed point 
belongs to the subject which received five days of intravenous cortisone just prior 
to the study' s termination and final testing. It is possible that this increase in 
strength is a reflection of that treatment. 
Changes in average peak torque, mean force, and fatigue slope did not exhibit 
any response pattern for the stimulation intensity tolerated either. Similar to the 
data of initial strength, a wide intersubject variability was displayed with minimal 
differences at either extreme of the stimulation intensity continuum. 
Lastly, the input from the questionnaire distributed after the study's end will 
be reviewed. Despite a wide range of responses in other aspects of this study, the 
sentiments expressed in the questionnaire are very similar. Seven out of nine 
forms were returned. It was not known how the stimulation would be tolerated 
by the subjects with MS since no previous studies had documented its use on 
individuals with MS. All subjects felt the stimulation improved the muscle being 
stimulated. Specific examples of improvement cited were increased strength (with 
improved functional performance), decreased muscle spasms, less muscle stiffhess, 
decreased edema, and decreased pain in the stimulated muscle, and sometimes the 
entire leg. The major complaint of the stimulation protocol revolved around the 3 
hour a day time requirement, although six out of seven still reported that they 
would repeat this stimulation protocol again. No adverse side effects were 
7 1  
reported as a result of the stimulation, and several subjects described the 
stimulation as being pleasant. Overall, the stimulation protocol was comfortable 
and well tolerated by the subjects. All subjects felt LFES had potential for 




The effects of a low frequency electrical stimulation protocol, as documented 
in previous animal and human subject research, have been investigated in this 
study in a practical application involving a clinical population. A low frequency 
electrical stimulation program of 8 Hz applied to the quadriceps muscle of 
individuals with MS did not produce a significant change in the maximum strength 
of the muscle, as assessed by peak torque and mean force measurements. The 
endurance of the muscle, as defined by a fatigue slope calculation, was far from 
the expected statistical significance. This was most probably due to decreases in 
the fatigability of both legs, and suggested the possibility of a cross-over effect. 
Although not significant at the . 05 probability level, a trend for improvement in 
the peak torque and mean force of the muscle was demonstrated, possibly 
suggesting an increase in the muscle's functional strength and endurance. 
The safe application of this type of LFES for both clinical and home use in 
individuals with MS has been demonstrated by this study. The 6 weeks of home 
use resulted in no reported problems as a result of using the portable stimulator. 
Subjective responses by the participants indicated that the stimulation is not only 
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comfortable, but beneficial in reducing edema, pain, and spasms in the stimulated 
muscle. Functional improvements were reported as well. 
The potential of a LFES to offer a viable short-term rehabilitation option to 
increase the functional strength and endurance of selected muscles in individuals 
with MS is suggested. Recognition is also given to the need for more research to 
further assess the effects of LFES in subjects with MS, in hopes of documenting 
changes in performance criteria s11;ggestive of a conversion of fast twitch muscle 
to slow twitch. Research must also determine the optimum parameters for clinical 
application. Details such as daily stimulation time, overall program duration, and 
the stimulation frequency and intensity offering the most beneficial results should 
be quantified by research. 
Other research concerns prompted by this study include: 
1 )  Determining if a longer program of LFES will exhibit greater changes in the 
performance criteria of a muscle. 
2) Investigating on a larger sample size whether changes in muscle strength or 
endurance vary according to the initial strength or functional ability of the 
individual . . 
3 )  Determining the relationship between the muscle assessment procedures of 
electrical stimulation testing and volitional muscle contraction technique. 
Inherent in this is discerning if muscle contractile changes demonstrated by 
electrical testing have any corollary in performance changes in the muscle. 
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4) Ascertaining where changes in performance criteria fit along the continuum of 
changes already demonstrated to occur in enzymatic activity, muscle contractile 
characteristics, myosin light chains, and histological fiber type. 
5) Investigating the role of a cross-over effect with stimulation when volitional 
testing procedures are used, particularly in subjects with CNS lesions. 
6) Lastly, histological fiber typing of the stimulated muscle before and after 
administration of a LFES program to reveal any changes in the muscle's 
morphology due to the stimulation, and to assess if results with LFES programs 
vary according to the initial fiber type predominance demonstrated. 
A final note relates to the clinical application of LFES program for individuals 
with MS. Perhaps it is most appropriate to view a LFES as an alternative method 
of providing an endurance training program with the additional benefit of being 
able to selectively target individual muscles which need it most. As suggested 
earlier, its greatest asset may be as a short term method of increasing a muscle's 
functional strength and endurance until volitional exercises can be initiated. This 
may be particularly helpful in individuals with MS by retraining specific muscles 
left weak after an exacerbation of the disease. 
The psychological impact to the individual must also be considered. 
Subjective responses by the participants in the study emphasized the 
encouragement and pleasure in seeing a weak muscle contract. Because of this, 
care must be used not to apply the electrical stimulation indiscriminately to any 
muscle group without first assessing the needs and goals of the area being treated. 
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It is tempting for an individual to apply the stimulation to many different muscles, 
since it is rewarding to see the weakened muscle contract. However, for each 
muscle to which the stimulation is applied, a separate evaluation is required to 
fine tune the electrical stimulation parameters. In this way, the most comfortable 
LFES program is delivered in the most efficacious manner. It should also be 
remembered that ascertaining many of the details of the most appropriate clinical 
protocol has yet to be determined by research. 
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SUBJECT HISTORY AND INFORMATION SHEET 
NAME: _______________ _ DA'IE: _______ _ 
AGE: _____ _ WEIGJIT: ____ _ SEX: ___ _ 
PHYSICIAN: _________________________ _ 
LAST APPOINTMENT: _________ NEXT APPOINTMENT: ______ _ 
MEDICAL HISTORY 
Years since disease diagnosis: _______________________ _ 
Frequency per year of exacerbations: _____ Average dmation of exacerbation: _____ _ 
Onset of last exacerbation: ________________________ _ 
Lower extremity tremors or spasms? ____ Frequency: ____ (per. /hour) ____ (per/day) 
History of heart disease? ______ Pacemaker?_______ Pregnant? ____ _ 
General heat tolerance: __________________________ _ 
MEDICATIONS: (List medications including how long on each) 
STRENGffl AND FUNCTIONAL STATUS: 
Any known disability ratings?______ Kurtzke EDSS rating according to table (0-9) __ _ 
Quadriceps strength: __________ (Riaht) ___________ (Left) 
Knee ROM: (Ri&bt) (Left) 
Cutaneous sensory status of thip:. _________ (Rigbt) _________ (Left) 
ACTMTY LEVEL: 
Currently participating in regular exercise? ___________________ _ 
Jfyes, for how long? ___________ Currently receiving physical therapy? ___ _ 
If yes, what kind and how long? ______________________ _ 
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Disabillty Status Scale in Multiple Sclerosis 
(In parentheses are listed usual equivalents for defects in the ftmctional systems.) 
0 - Normal neurologic examination (all grade O in .ftmctional systems) 
1 - No disabilitiy and minimal signs such as Babinski sign or vibratory decrease (grade I in ftmctional 
system) 
2 - Minimal disability, for example, slight weakness or mild gait, sensory, visuomotor disturbance (1 or 2 fimctional 
systems, grade 2) 
3 - Moderate disability though fully ambulatory (for example, monoparesis, moderate ataxia, or combinations of 
lesser dysfim.ctions) (1 or 2 fimctional systems, grade 3, or several, grade 2) 
4 - Relatively severe disability though fully ambulatory and able to be self-sufficient and up and about for some 
twelve hours a day ( 1 ftmctional system, grade 4, or several, grade 3 or less) 
5 - Disability severe enough to preclude ability to work a full day without special provisions. Maximal motor 
ftmction: walking maided no more than several blocks (1 fimctional system, grade 5 alone, or combination of lesser 
grades) 
6 - Assistance (canes, crutches, or braces) required for walking (combinations with more than 1 system, grade 3 or 
worse) 
7 - Restricted to wheelchair but able to wheel self and enter and leave chair alone ( combinations with more than 1 
system, grade 4 or worse; very rarely pyramidal , grade 5 alone) 
8 - Restricted to bed but with effective use of arms ( combinations usually grade 4 or above in several fimctional 
systems) 
9 - Totally helpless bed patients (combinations usually grade 4 or above in most fimctional systems) 
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April 10, 1994 
--------
Knoxville Neurology Clinic 
3 50 UT Professional Office Building 
Knoxville, Tennessee 3 7920 
Dear Dr. 
-----
I am a licensed physical therapist currently pursuing a Ph.D. in Exercise Science at the 
University of Tennessee. As part of that degree, I hope to conduct a research project on 
the effects of a low frequency electrical stimulation program on the quadriceps muscle of 
individuals with multiple sclerosis. 
The research protocol has been approved by the Human Subjects Review Committee at 
the University. I have also obtained approval from the National Multiple Sclerosis Society 
- Setenga Chapter - to recruit subject volunteers from area multiple sclerosis support 
groups. In so doing, one of you patients, ______ has expressed an interest in 
participating in the study. Acceptance into the study is contingent upon physician 
approval. I have enclosed a brief summary of the research protocol as well as an approval 
form for ______ . Also enclosed is a self-addressed stamped envelope for 
returning the form, should you approve. 
Thank - you for your time in considering your patient for study participation. I hope to 
begin data collection as soon as possil>le. For those individuals participating in the study, 
a follow-up letter upon study completion will be provided. 
Sincerely, 




Date: April 19, 1994 
The above individual has my permission to participate in the research protocol involving a 
low frequency electrical stimulation program to the quadriceps muscle of individuals with 
multiple sclerosis. 
Comments or special considerations for the above patient: __________ _ 
Has this individual been assessed by any disability scale rating? If so, would you please 
state the scale and the rating and the date given? _____________ _ 
Physician's Name: _______ MD 
Signature: __________ _ Date: ---------
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CONSENT FORM 
Title of Research Project: The Effects of a Low Frequency Electrical Stimulation 
Program on the Strength and Endurance of the Quadriceps Muscle in Individuals with 
Multiple Sclerosis 
Investigator: Lisa L. Oglesby, PT 
Department of Human Performance and Sport Studies 
University of Tennessee, Knoxville 
974-5 111  (UT); 549-8668 (pager) 
Description of Project: 
The pwpose of this investigation is to see if a low frequency electrical stimulation 
program causes any changes in strength or endurance in the thigh muscle of individuals 
with multiple sclerosis. It should be noted that this study is a research project to evaluate 
the effects of an electrical stimulation program and should not be considered as a physical 
therapy treatment program 
Procedures: 
After your physician's approva� the study will last approximately eight weeks. The 
first and last weeks will be used for testing the strength and endurance of both of your 
thigh muscles, at least two times each week, in the clinic. This will be done by your 
attempting to straighten your knee and hold it for five seconds against a machine that will 
indicate the strength and endurance of the muscle. 
During the middle six weeks of the study, you will use a portable electrical stimulation 
device in the convenience of your home. The electrical stimulation leve� and how long it 
is to be worn will be gradually increased up to two sessions a day, for one and one-half 
hours each session. This is to be done six days a week for six weeks. The duration of the 
stimulation will be increased fifteen minutes each day during the first week until the one 
and one-half hour maximum is reached. The intensity of stimulation will be ultimately 
determined by you based on your comfort level Generally, as you adjust to the feeling of 
the stimulation, greater intensity levels are possible. The device does not prevent your 
participation in most other simple activities, for example, walking around the house. I will 
visit your home weekly, or as needed, to provide assistance. 
Potential Risks and Benefits: 
Possible risks may include temporary discomfort due to the electrical stimulation 
sensation. You may also experience skin irritation under the electrode pad. Transient 
muscle soreness or muscle fatigue could also occur, but I have not seen this reported in 
the past. 
Possible benefits could be a small increase in strength or endurance of the muscle being 
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Consent Form - cont'd 
stimulated. However, past studies have shown any changes to be temporary and to last 
only as long as the stimulation continues. 
· A few studies involving healthy subjects with normal muscle strength have shown a 
slight decrease in maximal strength in conjunction with the increase in muscle endurance, 
ahhough this is not considered an abnormal response. Most studies involving muscles that 
are weak initially showed either no change or an increse in strength. 
The portable stimulation machine is safe for home use provided the following 
precaurions are followed. The equipment should not be worn while operating any 
machinery such as power tools or driving a car. The unit should be used only on the area 
of the body, as instructed, by the investigator. The unit should be kept away from 
children. 
Qualifications of Investigator: The investigator, Lisa Oglesby, is a licensed physical 
therapist familiar with the strength testing equipment and the stimulation device, and has 
worked with multiple sclerosis individuals in the past. 
Authorization: 
I have read the above information and understand my role in this project as well as the 
risks involved. I have had the procedure explained and demonstrated to me. In addition, I 
am aware that: 
I .  My name and my results will remain confidential. Any reference to my 
participation in the study will be by an assigned subject number. Only the principal 
investigator will know the number assigned to me; 
2. I am entitled to have any further inquiries answered regarding the procedure; 
3 .  Participation in the study is voluntary; refusal to participate will involve no penalty, 
and I may with draw or discontinue my participation at any time. 
4. In the event that physical injury occurs as a result of the study, the University of 
Tennessee does not automatically provide reimbursement for medical care, or other 
compensation. If physical injury is suffered in the course of research, or for more 
information, please notify the principal investigator, Lisa Oglesby at 549-868 (pager). 
My signature also indicates that I have received a copy of this consent form. 





TESTING DATA SHEET 
NAME: __ ________ _ 
Checklist of Cybex Settings: 
Calibration Date: 
Foiward/backward lever arm setting: 
Up/down lever arm setting: 
Ankle resistance lever arm setting: 
(Lower border superior to lateral malleolus) 
Foot pom1ds scale: 





Hip Strap/Knee Strap: 
Ankle Pad Secure: 
Foot against backstop and locked: 
Data: 
Practice (three light trials): 
Needle on zero line? 
1st MVIC with five second bold: 
R�zero; Foot back and relax: 
2nd MVIC with five second bold: 
R�zero; Foot back and relax: 
3rd MVIC with five second hold: 
SUBJECT NUMBER: ___ _ 
Session One 
Date: 
Tlmefl'emp: __ _ 




Tlme/l'emp: __ _ 
Rt leg Lt leg 
Motor Point Chart for Lower Extremity 
Vastus Lateralis 
Vastus Medialis 
Adapted from: Shnoer WJ. A Manual ofElectrotherapy 4th ed. 1975, p152. 
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STIMULATION PROGRESSION SHEET AND TIME LOG 
Instructions: I. Please record the clock time of the session in the boxes below. Example: 2:00 - 2: 1 5  pm 
Week One: 
Day 
2. Note the schedule of increasing stimulation time dming the first week up to 90 minutes. 
After this is reached, continue with 1 hour and 30 minutes, each session, for the rest of 
the program. Remember, you have one day off each week. 
3. After the first week, increase the intensity of the stimulation ( by twning up the dial ), 
within what is comfortable for you, to maintain a good contraction in the muscle. 
4. Record the dial setting in the comments box, along with any other comment 
Additional space for comments is provided below each week's stimulation box. 
Date First Session Second Sesssion Dial Setting/Comments 
(15 min) (15 min) 
(30 min) (30 min) 
(45 min) (45 min) 
(60 min) (60 min) 
(75 min) (75 min) 
(90 min) (90 min) 
(90 min) (90 min) 
Comments: ________________________________ _ 
Week Two: 
Dav Date First Session Second Session Dial Setting /Comments 
(90 min) (90 min) 
(90 min) (90 min) 
(90 min) (90 min) 
(90 min) (90 min) 
(90 min) (90 min) 
(90 min) (90 min) 




Dav Date First Session Second Session Dial Settinw'Comments 
(90 min) (90 min) 
(90 min) (90 min) 
(90 min) (90 min) 
(90 min) (90 min) 
(90 min) (90 min) 
(90 min) (90 min) 
(90 min) (90 min) 
Comments:. ________________________________ _ 
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STIMULATION TIME LOG - Continued 
Week Four: 
Day Date First Session Second Session Dial Setting/Comments 
(90 min) (90 min) 
(90 min) (90 min) 
(90 min) (90 min) 
(90 min) (90 min) 
(90 min) (90 min) 
(90 min) (90 min) 




Day Date First Session Second Session Dial Setting/Comments 
(90 min) (90 min) 
(90 min) (90 min) 
(90 min) (90 min) 
(90 min) (90 min) 
(90 min) (90 min) 
(90 min) (90 min) 
(90 min) (90 min) 
Comments: _______________________________ _ 
Week Six: 
Day Date First Session Second Session 
Dial Setting/Comments 
(90 min) (90 min) 
(90 min) (90 min) 
(90 min) (90 min) 
(90 min) (90 min) 
(90 min) (90 min) 
(90 min) (90 min) 
(90 min) (90 min) 
Comments: _________________________
______ _ 
Please call me on my pager if you have any questions. 
To reach me by pager, dial 549-8668. After the recorded message, dial your phone number followed 
by the # sign on the phone pad, then hang up. I will call you back as soon as I can get to a phone. 
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Follow-up Questionnaire for Electrical Stimulation Program 
Name: _______ (Optional) 
1. Do you feel the electrical stimulation program made a difference, for better or worse, 
in the muscle, or leg being stimulated? 
------------------
If so, please give any specific examples you can think of _________ _ 
2. Have you been able to notice any difference in the leg since you stopped the electrical 
stimulation? 
-------------------------------
3. What did you dislike most about the electrical stimulation program? _____ _ 
4. What did you like most about the electrical stimulation program? _______ _ 
5. Do you think you would be likely to do this type of electrical stimulation program (3 
hours a day, six days a week, for six weeks) again to either the same part of the body or to 
a different part of the body? ____________________ _ 
6. Do you think you would be more likely to participate in such a program if it were for a 
shorter period of time each day, say for two hours instead of three? _______ _ 
7. Do you think you would be likely to use it if it neede to be done for twelve weeks 
instead of six? 
--------------------------
8. If you could do exercises to provide an effect similar to the electrical stimulation, do 
you think that you would be more likely to exercises six days a week, or the electrical 
stimulation? Why? ________________________ _ 
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Questionnaire continued 
9. Do you see this type of electrical stimulation program being helpful to individuals with 
multiple sclerosis? Any particular reason why you feel this way? ________ _ 
10. Any oter comments or ideas? __________________ _ 
Thanks for taking the time to participate in the study and to fill out the questionnaire. I 
really appreciate your help ! 
Lisa Oglesby 
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ANOV A Summary Tables for Experimental vs Control 
Prior to Electrical Stimulation 
For Average Peak Torgue: 
Source of variation DF Sum of Squares 
Subjects 8 23401 .353 
group 1 144.897 
Error 8 4803.662 
For Average Mean Force: 
Source of Variation DF Sum of Squares 
Subjects 8 1 8374. 582 
group 1 52.839 
Error 8 4093.036 
For Average Fa!!gue Sloee: 
Source of Variation DF Sum of Squares 
Subjects 8 329.355 
group 1 2.683 
Error 8 37. 897 
Mean Square 






5 1 1 .630 
Mean Squares 
















F p Epsilon Correction 




Experimental Control Experimental Control 
#1 : APT 29.94 65.54 23.64 59.22 
AMF 23.35 53.03 21.06 47.91 
AFS 10.74 7.60 5.21 7.49 
#2 APT 110.74 92.66 106.89 95.15 
AMF 97.84 85.20 97.66 88.34 
AFS 6.07 5.17 4.41 4.84 
#3 APT 61.47 48.56 71.19 54.69 
AMF 55.19 42.99 65.68 52.06 
AFS 4.88 6.87 3.44 2.63 
#4 APT 20.65 35.39 32.68 35.49 
AMF 20.23 30.84 32.31 35.15 
AFS 2.27 5.99 1.22 1.60 
#5 APT 89.73 52.88 98.65 47.23 
AMF 88.14 44.78 95.60 39.30 
AFS 1.5 7.76 2.67 11.03 
APT 89.27 165.88 127.46 179.44 
AMF 77.94 144.25 111.87 · 155.80 
AFS 13.80 10.89 7.96 8.83 
#7 APT 16.95 32.77 22.33 45.66 
AMF 16.53 32.50 21.97 45.33 
AFS 1.4 .48 1.02 .50 
#8 APT 10.08 7.01 14.51 9.53 
AMF 6.63 4.37 10.88 7.00 
AFS 14.69 15.86 11.19 10.18 
#9 APT 52.89 32.10 81.81 44.07 
AMF 51.05 29.78 77.71 41.90 
AFS 3.11 4.79 4.03 3.01 
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For Average Peak Torque: 
ANOV A Summary Tables 
for Treatment Effects 
... source. of Variation ....... DF ........ sum of Squares ........ Mean _Squares ....... F ................ P ................ Epsilon Correction ... .. . 
Subjects 8 5 1 503 .662 6437.958 
time 1 507.225 507.225 4.958 .0566 
Error 8 81 8.354 102.294 1 .00 
group 1 49.914 49.914 .044 .8390 
Error 8 9069.846 1 133 .73 1 1 .00 
t X g 1 99. 168 99. 168 3 .288 . 1 073 
Error 8 241.252 30. 156 1 .00 
For Average Fa!igue Slo,ee: 
-· Source _of Variation ....... OF ....... Sum. of_Squares ....... Mean _Square ..... ...F ................ P ................ Epsilon _Correction .... . 
Subjects 8 464.880 58 . 1 10 
time 1 29.539 29.539 6.442 .0348 
Error 8 36.684 4.585 1 .00 
group 1 7.03 1 7.03 1 1 . 064 .3325 
Error 8 52. 870 6.609 1 .00 
t x g  1 . 1 12 . 1 12 .045 . 838 1  
Error 8 20. 148 2. 5 19  1 .00 
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ANOV A Table: 
ANOV A Summary Table and Simple Effects 
for Average Mean Force 
... Source. of Variation ....... DF ........ Sum of Squares ........ Mean Square ....... F ................. P ................ Epsilon. Correction .... . 
Subjects 8 40195.096 5024.387 
time 1 567. 154 567. 154 7.55 1 .025 1 
Error 8 600.91 1 75 . 1 14 1 .00 
group 1 2. 195 2. 195 .002 .9635 
Error 8 7861 .08 1 982.635 1 .00 
t X g 1 77.41 1 77.4 1 1  3.495 .0985 
Error 8 177. 1 84 22. 148 1 . 00 
Simple Effects for time x group interaction: 
... Effect ................. MSn .............. DFn ....... DFe ....... MSe .............. F ................ P ......... .. 
t at  exp 53 1 . 8 15 1 8 72.683 7.3 17  .027 
t at control 1 12. 750 1 8 24.579 4.587 .065 
g at pre 52. 839 1 8 5 1 1 .630 . 103 .756 
gat� 26.767 I 8 493. 154 . 054 . 822 
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Vita 
Lisa Lillard Oglesby graduated from high school in 1974 in Memphis, Tennessee. A 
Bachelor of Arts was awarded in December 1977 from the University of Tennessee, 
Knoxville, followed by a Bachelor of Science in Physical Therapy in 1979 from the 
University of Tennessee Center for the Health Sciences in Memphis. Since that time, she 
has worked in a variety of physical therapy settings including acute care, home health care, 
orthopedic rehabilitation, and private practice in Tennessee and Arizona. For six of these 
years, she also was a navigator on a KC-135 refueling aircraft in the Tennessee Air 
National Guard. 
The past three years have been dedicated to obtaining a Doctor of Philosophy in 
Exercise Science at the University of Tennessee to further her professional career. 
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